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Primary Care in the Twenty-first Century
Realising the promise of rapid service access and well-coordinated person 
centred health and social care at every stage of life
Summary
•	 The	NHS	remains	one	of	the	world’s	better	health	care	systems.	But	the	proportion	of	the	UK’s	GDP	allocated	
to	health	and	social	care	is	only	about	three	quarters	of	that	now	spent	by	leading	European	nations.	To	meet	
changing	needs	health	and	social	care	providers	in	England	must	improve	their	capacity	to	offer	convenient	
access	to	preventive	and	‘common	need’	diagnostic	and	treatment	services	to	people	of	all	ages,	and	also	
to	provide	well-coordinated	social	and	health	care	to	individuals	at	high	risk	of	suffering	avoidable	episodes	of	
serious	illness	and	needlessly	losing	their	independence.
•	 If	personal	and	public	health	is	to	be	raised	to	the	highest	possible	level	improving	primary	health	and	health	
related	social	care	–	which	together	represent	little	more	than	a	fifth	of	combined	NHS	and	local	authority	social	
service	outlays	–	is	vital.	Health	care	will	in	future	move	more	towards	professionally	facilitated	prevention	and	
primary	care	supported	self-care	in	the	community,	backed	by	the	relatively	infrequent	use	of	highly	specialised	
services	supplied	in	hospitals.
•	 The	unique	attributes	of	British	general	medical	practice	will	allow	it	to	serve	as	a	central	plank	for	continuing	
service	development.	The	formation	of	local	Health	Federations	and	related	primary	care	focused	organisations	
could	in	future	lend	itself	to	holding	single	budgets	for	health	and	related	social	care	along	the	lines	proposed	by	
advocates	of	the	Primary	Care	Home	approach	to	service	improvement.	This	would	offer	significant	gains	for	
service	users.	Wherever	cost	effective,	services	ought	to	be	‘made’	by	local	care	providers.	Where	necessary	
they	should	be	purchased	from	other	sources.
•	 There	is	a	large	body	of	evidence	indicating	that	Community	Pharmacy	can	play	an	extended	part	in	delivering	
accessible	health	care,	alongside	roles	like	reducing	prescription	errors	and	facilitating	better	medicines	use.	
Increasing	the	number	of	clinical	pharmacists	working	in	GP	practices	is	a	valuable	step.	But	it	cannot	substitute	
for	a	clear	vision	for	the	future	of	community	pharmacies	as	‘first	contact’	health	care	providers.
•	 If	 community	pharmacists	 successfully	 extend	 their	 clinical	 care	 roles	 this	would	 free	general	practice	and	
linked	 community	 capacity	 to	 work	 towards	 reducing	 inappropriate	 hospital	 admissions	 and	 unduly	 long	
inpatient	 stays.	Without	well	 planned,	pro-active,	 interventions	pharmacy	 skills	will	 be	under-used	and	 the	
established	community	pharmacy	network	lost.	Yet	if	each	community	pharmacy	in	England	were	able	to	take	
on	just	10	per	cent	of	the	average	general	practice’s	existing	workload	over	the	next	five	years,	this	will	release	
approaching	5,000	GPs	and	similar	volumes	of	practice	staff	for	additional	service	provision.
•	 Responsibility	for	achieving	more	effective	primary	care	working	arrangements	lies	mainly	with	GPs,	nurses,	
social	workers	and	pharmacists	 themselves,	because	only	 they	are	 in	a	position	 to	adequately	understand	
the	tasks	with	which	they	are	engaged	and	the	detailed	needs	of	the	people	they	serve.	However,	individual	
professionals	 alone	 cannot	 transform	 the	NHS.	 Excellent	 national	 leadership	 and	 appropriate	 funding	 and	
governance	systems	are	also	vital	for	nation-wide	success.
•	 Nine	out	of	10	people	 in	England	currently	 live	within	a	20	minute	walk	of	 a	community	pharmacy.	Some	
planners	may	wish	to	see	savings	made	via	concentrating	dispensing	in	warehouse-like	facilities	and	increasing	
the	 use	of	medicines	 home	delivery	 services.	Yet	 at	 a	 system-wide	 level	 a	 potentially	more	desirable	way	
forward	could	be	to	extend	pharmacist	prescribing	and	 improve	shared	health	record	systems.	This	would	
combine	convenient	 local	medicines	 supply	with	more	accessible	 forms	of	 ‘pharmacist	 first’	 care	 in	 areas	
ranging	from	managing	blood	pressure	to	providing	better	chronic	obstructive	pulmonary	disease	(COPD)	and	
type	2	diabetes	prevention	and	care.
•	 The	health	and	social	care	system	in	England	has	been	affected	by	imbalances	that	are	linked	to	the	fact	that	
social	care	is	means	tested	while	NHS	care	is	free.	This	has	created	perverse	incentives	that	may	in	the	past	
have	undermined	services	such	as	community	nursing.	Inadequate	high	level	leadership	also	impairs	service	
quality.	But	 if	health	gain	focused	co-operative	professional	enterprise	can	be	combined	with	well-informed	
decision	making	and	robust	national	and	local	resource	allocation	strategies	that	effectively	support	the	delivery	
of	well-coordinated	primary	care,	further	improvements	in	individual	and	population	health	will	be	achieved.
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Introduction
Sophisticated	 hospital	 care	 can	 be	 life-saving,	 or	 play	
an	important	part	in	preventing	and	alleviating	disabilities	
and	 restoring	 normal	 daily	 activities.	 Even	 after	 hopes	
of	cure	have	faded,	hospital	treatments	extend	survival	
and	relieve	acute	distress.	When	people	refer	to	Britain’s	
National	 Health	 Service	 as	 being	 one	 of	 the	 world’s	
best	health	care	systems	 it	 is	 frequently	because	of	 its	
capacity	to	offer	access	to	hospital	care	–	the	provision	
of	 which	 is	 conventionally	 estimated	 to	 account	 for	
around	 two	 thirds	 of	 all	 UK	 health	 service	 spending	 –	
without	individuals	having	to	worry	about	its	immediate	
affordability	for	them	and	their	families.
The	 continuing	 ability	 of	 the	 NHS	 in	 England	 and	 the	
other	UK	countries	to	provide	‘cutting	edge’	acute	and	
elective	hospital	 care	 to	people	 in	 exceptional	medical	
need	will	remain	essential	if	it	is	to	go	on	being	trusted.	
However,	 for	 public	 health	 to	 be	 raised	 to	 the	 highest	
standards	 possible,	 and	 for	 people	 living	 with	 long-
term	 conditions	 and	 established	disabilities	 to	 be	 able	
to	maximise	their	wellbeing,	excellence	in	the	delivery	of	
‘high	technology	medicine’	in	institutional	settings	alone	
is	not	enough.	 It	must	be	accompanied	by	 the	 robust	
provision	of	primary	health	care	(including	–	as	primary	
care	is	defined	here	–	community	nursing	and	pharmacy,	
and	also	 community	mental	 health	 care)	 together	with	
social	 services	 that	 offer	 high	 quality	 support	 for	 daily	
living	and,	when	it	is	needed,	access	to	residential	care.
Total	 NHS	 spending	 on	 ‘family	 practitioner	 services’	
(including	 all	 community	 medicines	 costs,	 and	 public	
spending	 on	 general	 dental	 and	 ophthalmic	 services)	
today	 accounts	 for	 only	 a	 fifth	 of	 total	 health	 service	
outlays.	Yet	 the	work	of	GPs,	 community	pharmacists	
and	 other	 primary	 care	 professionals	 is	 central	 to	 the	
cost	 effective	 provision	 of	 health	 care	 as	 a	 whole.	 In	
well-functioning	systems,	primary	care	provided	by	not	
only	GPs	but	also	health	professionals	 like	nurses	and	
pharmacists	 provides	 ‘first	 contact’	 support	 across	
populations	 that	 is	 when	 it	 is	 required	 to	 be	 person-
centred,	continuous	(that	is,	is	based	on	relationships	that	
endure	over	time)	comprehensive	and	well-coordinated	
–	see	Box	1.
Primary	 care	 services	 should	 also	 be	 convenient	 and	
pleasant	 to	 use	 as	measured	 by	 the	 standards	 of	 the	
communities	 in	 which	 they	 are	 provided,	 and	 able	 to	
respond	 quickly	 and	 reliably	 at	 the	 interface	 between	
self-care	 and	 professionally	 delivered	 interventions.	
There	is	robust	evidence	that	a	good	relationship	with	a	
freely	chosen	primary	care	doctor,	preferably	sustained	
over	 years,	 is	 associated	with	 better	 health	 outcomes	
than	would	otherwise	be	possible	(Starfield	et	al,	2005).	
NHS	general	practice	has	been	described	as	‘the soul 
of a community orientated health-preserving system’	
(Berwick,	2008).
Effective	primary	care	complements	and	 reinforces	 the	
impacts	of	‘impersonal’	public	health	programmes	aimed	
at	 creating	 protective	 environments	 and	 stimulating	
beneficial	behavioural	changes	across	entire	populations.	
It	also	enables	specialised	disease-centred	interventions	
to	 take	place	 in	 timely	 and	optimally	 productive	ways.	
Without	 good	 primary	 care,	 hospitals	 are	 inevitably	
burdened	by	avoidable	or	unduly	late	admissions	and	by	
inappropriately	delayed	discharges.
As	 Figure	 1	 outlines,	 the	 activities	 of	GPs,	 community	
pharmacists	 and	 allied	 service	 providers	 range	 from	
primary	 prevention	 (disease	 avoidance	 via	 measures	
ranging	 from	 immunisation	 to	 smoking	 cessation)	 and	
responding	to	trauma	and	acute	symptoms	through	to	
providing	diagnoses	and	referrals	to	specialists.	Primary	
care	 practitioners	 also	 provide	 secondary	 prevention	
(early	stage	disease	 treatment)	and	support	 for	people	
with	 long	 term	 conditions,	 and	 can	 be	 central	 to	 late	
stage	illness	and	end-of-life	care.
The	needs	of	children	and	young	adults	are	normally	very	
different	from	those	of	people	in	their	eighties	and	above.	
Even	 within	 age	 groups	 individuals’	 requirements	 vary	
widely.	Yet	primary	care	as	a	whole	should	be	inclusive	
and	offer	a	set	of	familiar	‘front	doors’	to	health	and	allied	
care	to	all	members	of	the	community.
Figure	 2	 is	 indicative	 of	 the	 changing	 nature	 of	 health	
and	 social	 care	 and	 the	 potential	 for	 community	
pharmacy	to	–	in	constructive	partnership	with	General	
Practice	 –	 play	 an	 increased	 part	 in	 meeting	 modern	
service	needs.	Demand	for	enhanced	primary	care	will	
continue	to	expand	as	new	health	technologies	present	
fresh	opportunities	for	prevention	and	treatment	outside	
hospitals	 and	 GP’s	 surgeries,	 and	 increased	 levels	 of	
education	and	access	to	information	change	public	and	
professional	 understandings	 of	 health	 and	 illness	 and	
generate	new	service	expectations.	Twenty	first	century	
health	 care	 will	 almost	 certainly	 move	 further	 in	 the	
direction	of	professionally	facilitated	preventive	self-care	
in	the	community,	backed	by	the	relatively	infrequent	use	
of	highly	specialised	services	in	hospitals.
General	Medical	Practitioners	have	always	been	central	
to	 NHS	 primary	 care.	 For	 many	 people	 their	 General	
Practice	(and,	within	it,	their	GP)	is,	especially	after	they	
have	had	children	or	have	entered	the	later	stages	of	their	
lives,	their	natural	 ‘Primary	Care	Home’	(Colin-Thomé	,	
2011).	 At	 best,	 primary	 care	 provides	 places	 in	which	
individuals	are	known,	and	to	which	they	choose	to	go	
when	 seeking	 to	 cope	 with	 health	 related	 challenges	
because	they	trust	that	they	will	receive	good	guidance	
and	support.	There	is	evidence	that	competent	general	
medical	 practitioners	 manage	 risks	 and	 identify	 self-
limiting	conditions	that	do	not	need	further	investigation	
with	 a	 relatively	 high	degree	of	 reliability,	 as	compared	
to	 colleagues	 with	 more	 narrowly	 focused	 medical	
expertise.
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Box 1. Good Primary Care
The	 development	 of	 consistent,	 person	 focused	 and	
technically	robust	primary	care	services	aimed	at	both	
the	delivery	of	excellent	 individual	support	and	public	
health	 improvement	 has	 for	 many	 decades	 been	
recognised	as	central	to	the	pursuit	of	‘health	for	all’.	In	
1978,	for	example,	the	Alma	Ata	declaration	called	on	all	
governments	to	invest	in	improving	primary	care	as	the	
cornerstone	of	effective	health	services	development.	
More	recently	the	current	Director-General	of	the	WHO	
noted	 that	 international	 evidence	 overwhelmingly	
demonstrates	 that	 health	 systems	 oriented	 towards	
primary	health	care	produce	better	outcomes,	at	lower	
costs	 and	 with	 higher	 user	 satisfaction,	 than	 more	
hospital	centric	systems.
The	 available	 literature	 (see,	 for	 instance,	 Chambers	
and	 Colin-Thomé,	 2008)	 identifies	 the	 hall-marks	 of	
good	primary	care	as	including:
•	comprehensive	 first	 point	 of	 contact	 care	 that	 is	
conveniently	accessible	for	all	members	of	a	community,	
and	which	covers	all	common	health	needs;
•	continuous	person	and	family	focussed	care,	consistent	
with	individual	requirements	for	privacy	and	choice;
•	the	effective	and	systematic	management	of	chronic/
long	term	diseases;
•	referral	 to	 and	 the	 coordination	 of	 outpatient	 and	
inpatient	specialist	care	as	and	when	appropriate;	and
•	care	for	the	health	of	entire	populations	as	well	as	that	
of	each	person	within	them.
In	 countries	 like	 the	 UK	 today	 high	 quality	 primary	
provision	also	involves	medical	and	pharmaceutical	care	
in	residential	homes,	and	the	capacity	to	offer	tailored	
support	 to	 ethnic	 minorities.	 However,	 although	 the	
centrality	of	good	primary	and	associated	community	
care	and	preventive	services	is	widely	acknowledged,	
there	are	often	pressures	that	can	serve	to	draw	funds	
away	from	such	areas	into	higher	cost	secondary	and	
tertiary	care	centres.
Further,	even	though	research	indicates	that	most	NHS	
primary	 medical	 care	 is	 of	 good	 standard	 there	 are	
nevertheless	 reasons	 to	 believe	 that	 further	 progress	
could	be	made	in	areas	ranging	from	prescribing	and	
helping	patients	take	medicines	to	best	effect	through	
to	 improving	 early	 stage	 disease	 diagnosis	 and	 the	
better	 coordination	 of	 home	 support.	 Better	 joint	
working	between	health	 professionals	who	 are	 either	
co-located	or	working	in	good	communication	across	
different	sites	can	contribute	 to	such	goals,	providing	
all	those	involved	are	adequately	motivated	to	improve	
overall	health	and	social	care	outcomes.
Figure 1: Primary Health and Social Care Figure 2: The Direction of Health Care 
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As	well	as	providing	diagnoses	and	care	directly,	a	central	
role	 for	 general	medical	 practice	 as	 a	 specialism	 is	 to	
efficiently	 manage	 risk	 and	 route	 individuals	 requiring	
interventions	that	cannot	be	made	in	the	practice	setting	
to	other	appropriate	providers	(Forrest	et	al	2006;	Foot	
et	al,	2010).	However,	General	Practice	is	not	always	as	
highly	valued	as	 its	proponents	believe	 it	ought	to	be.1	
Sociologically,	this	may	in	part	be	because	GPs	can	be	
seen	as	bridging	the	gap	between	‘scientific	medicine’	
and	 less	 technical,	 more	 personal,	 forms	 of	 care	 and	
support.
But	even	if	is	true	that	GPs	by	virtue	of	their	roles	have	
stronger	 insight	 into	 the	psycho-social	needs	of	health	
service	 users	 than	many	 hospital	 based	 professionals	
and	also	 that	 the	quality	of	most	of	 their	 care	 is	good	
(Goodwin	et	al,	2011),	 there	 is	 long-standing	evidence	
of	 difficulties	 and	 discontinuities	 in	 NHS	 primary	 and	
linked	 Local	 Authority	 social	 care	 provision	 in	 relation	
to	 both	 physical	 and	mental	 health.	 There	 is	much	 to	
commend	 NHS	 general	 medical	 practice.	 Yet	 overall	
1	 Famously,	in	1958	Lord	Moran,	then	the	President	of	the	
Royal	College	of	Physicians,	observed	that	there	was	a	career	
ladder	in	medicine,	and	that	it	was	one	‘off	which	they	[General	
Practitioners]	fell’.	Despite	the	progress	of	the	last	half	century	
such	negative	attitudes	can	still	be	found	today,	not	least	amongst	
the	memberships	of	some	hospital	Trust	Boards.	Similar	divides	
exist	in	professions	like	pharmacy.
standards	of	community	care	often	fall	short	of	the	ideal,	
in	part	because	of	coordination	problems.	There	are	now	
opportunities	to	correct	such	failings.
Questions	about	primary	care	fitness	for	purpose	are	not	
new.	They	date	back	to	the	1950s	and	before	–	see,	for	
example,	the	1920	‘Dawson	Report’	and	Collings,	1950.	
Box	2	highlights	some	of	the	findings	of	these	analyses.	
Reforms	such	as	those	introduced	via	the	1966	‘Doctors’	
Charter’	(which	restricted	the	size	of	individual	GP	‘lists’	
and	encouraged	 increased	practice	 staffing	and	 larger	
GP	partnerships	–	at	that	time	a	majority	of	British	GPs	
still	 worked	 alone	 or	 in	 two	 handed	 partnerships)	 and	
later	measures	like	the	establishment	of	the	NHS	internal	
market	sought	to	strengthen	the	NHS	through	enhancing	
primary	 care	 and	 its	 capacity	 to	 play	 a	 central	 role	 in	
delivering	 services	 or	 guiding	 their	 improvement.	 So	
too	did	the	more	recent	creation	(in	England)	of	Clinical	
Commissioning	Groups	(CCGs)	and	NHS	England.
Yet	 the	 extent	 to	 which	 such	 measures	 have	 been	
successful	in	achieving	their	declared	ends	is	–	to	date,	
at	 least	–	at	best	questionable.	As	with	 the	polyclinics	
advocated	during	the	last	Labour	administration	(Darzi,	
2008),	suggested	forms	of	progress	have	often	sought	to	
generate	efficiencies	via	the	formation	of	bigger	primary	
care	 organisations	 and	 through	 service	 ‘integration’	
in	 the	 sense	 of	 co-locating	 GPs	 with	 not	 only	 wider	
Box 2. From Dawson to Collings
Following	 the	 end	 of	 the	 first	 world	 war	 the	 then	
Liberal	 politician	 Christopher	 Addison	 (a	 doctor	 who	
subsequently	 became	 Leader	 of	 the	House	 of	 Lords	
during	 the	 1945-51	 Attlee	 administration)	 sought	 to	
transform	 the	 then	 Local	 Government	 Board	 into	 a	
new	Ministry	of	Health.	He	became	the	first	Minister	of	
Health	in	1919.
Because	 of	 ‘austerity’	 linked	 concerns	 about	 health	
spending	Addison	 lost	 this	position	within	 two	years,	
but	not	before	he	had	commissioned	a	radical	report	by	
the	Royal	physician	and	war	hero	Sir	Bertrand	Dawson	
(who	became	Lord	Dawson)	on	the	future	provision	of	
medical	and	allied	services.	An	interim	document,	which	
became	known	as	the	Dawson	report,	was	published	
in	1920	(Dawson,	1920).	This	strongly	advocated	the	
formation	 of	 an	 integrated	 primary	 and	 secondary	
health	centre	based	system.	Although	no	further	action	
was	 instituted	 at	 the	 time,	 this	 pioneering	 analysis	
subsequently	underpinned	arguments	in	favour	of	the	
formation	of	a	systematically	structured	national	health	
service.
However,	when	in	part	due	to	the	continuing	efforts	of	
individuals	 such	 as	Addison	 the	NHS	was	 eventually	
established	 in	 1948	 it	 pragmatically	 combined	
arrangements	 that	 had	 independently	 evolved	 in	 the	
preceding	half	 century.	General	medical	 practice	 and	
community	pharmacy	were	 (along	with	 local	authority	
based	 service	 assets	 such	 as	 district	 nursing	 and	
public	health	expertise)	 important	elements	within	the	
original	NHS.	But	 they	were	 not	 joined	 together	 in	 a	
well-coordinated	manner,	and	their	quality	was	at	best	
‘patchy’.
The	 latter	 fact	 was	 highlighted	 in	 1950	 by	 a	 survey	
published	 in	 the	 Lancet	 by	 an	 Australian	 doctor	 and	
qualitative	 ethnographic	 researcher	 called	 Joseph	
Collings	(Collings,	1950).	He	had	been	commissioned	
by	 the	 Nuffield	 Trust	 to	 assess	 the	 state	 of	 general	
medical	practice	in	the	NHS.
In	 fact	 his	 work	 was	 never	 fully	 published.	 Yet	 what	
did	 become	 available	 revealed	 many	 reasons	 for	
concern	about	the	then	isolated	and	poorly	supported	
situation	 of	 GPs.	 Collings	 judged	 general	 medical	
practice	to	be	an	anachronism	which	needed	rapid	and	
comprehensive	change.	This	view	was	initially	rejected	
(Wilkie,	2014).	However,	starting	with	the	formation	of	
the	then	College	of	General	Practice	 in	1952	and	the	
BMA	 published	 1954	 Hadfield	 report	 Good General 
Practice,	 it	 in	 time	 opened	 the	 way	 to	 fundamental	
reform	 via	 an	 adaptive	 incremental	 process	 which	
in	 contexts	 like	 the	 interfaces	 between	 community	
pharmacy,	 general	 practice	 and	 community	 nursing	
has	continued	through	to	the	present.
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multi-disciplinary	health	and	social	care	teams	but	also	
specialist	physicians.	The	pursuit	of	performance	gains	
via	the	more	assertive	managerial	planning	and	direction	
of	 professional	 work	 has	 typically	 been	 implicit	 in	 this	
sort	of	approach.
There	have	also	been	multiple	efforts	to	further	develop	
community	pharmacy	and	nursing	services	in	England,	
Scotland	and	the	other	UK	nations.	 (See,	 for	 instance,	
Clukas,	 1986;	 DHSS,	 1986;	 DoH,	 2000;	 Scottish	
Executive,	 2002;	 Smith	 et	 al,	 2013,	 2014.)	 But	 the	
degree	to	which	such	 initiatives	have	 in	 reality	enabled	
NHS	 primary	 and	 LA	 social	 care	 providers	 to	 work	
together	 in	 less	 fragmented,	 more	 efficient,	 ways	 and	
adapt	pro-actively	 to	 the	changing	requirements	of	 the	
people	 they	 serve	 is	 again	 questionable.	 Inadequately	
coordinated	 approaches	 represent	 a	 significant	 barrier	
to	improving	outcomes	in	areas	such	as	providing	high	
quality,	affordable,	services	for	older	people	with	complex	
care	and	support	needs	(Humphries,	2015).
At	worst,	 some	NHS	 improvement	 attempts	 could	 be	
accused	 of	 being	 based	 on	 ‘magic	 thinking’,	 rather	
than	 carefully	 evaluated	 evidence	 and	 well-designed	
implementation	 strategies.	 Some	 of	 the	 professionals	
interviewed	 during	 the	 preparation	 of	 this	 report	 said	
that	 declining	 primary	 and	 community	 care	 resources	
relative	 to	 NHS	 total	 spending,	 coupled	 with	 rising	
patient	demands,	unwanted	organisational	disruptions,	
increasing	bureaucracy	and	a	shortage	of	young	doctors	
willing	to	enter	general	practice,	mean	that	today	‘it has 
never been more difficult to be a GP.’ However,	another	
very	experienced	doctor	said	‘I cannot remember a year 
when there was not low morale – its normal’.
There	 is	 also	 evidence	 of	 pharmacist	 and	 community	
nursing	 discontent,	 albeit	 NHS	 services	 have	 to	 date	
been	much	better	protected	from	‘austerity’	than	social	
care	and	other	Local	Authority	services	like	–	for	instance	
–	 ongoing	 adult	 education	 for	 people	 with	 learning	
disabilities.	Claims	of	there	being	a	crisis	in	primary	care,	
or	in	the	NHS	more	widely,	should	therefore	be	viewed	
with	some	caution	(Dayan	et	al,	2014).	They	are	in	part	
linked	 to	 conflicts	 about	 whether	 or	 not	 UK	 (public)	
health	care	 funding	should	be	strictly	cash	 limited	 that	
date	back	at	least	to	the	start	of	the	1950s,	and	might	
even	be	 linked	 to	 a	 national	 debate	 that	 began	 in	 the	
aftermath	of	World	War	1.
Such	disputes	should	arguably	be	regarded	as	normal	
in	democratically	led,	politically	controlled,	environments.	
On	some	occasions	funding	and	performance	problems	
may	 be	 over-stated,	 and	 on	 others	 they	 have	 been	
misstated.	 The	 NHS	 has	 often	 been	 characterised	
by	what	appear	 to	be	scandal	 led	changes	or	 ‘shock’	
reorganisations,	 rather	 than	 well	 directed	 incremental	
evolution.
However,	even	if	the	underlying	health	service	situation	
is	 more	 robust	 than	 is	 sometimes	 suggested,	 there	
are	 from	 a	 patient	 perspective	 substantive	 primary	
care	 linked	problems	ranging	from	the	time	 it	can	now	
take	to	get	a	GP	appointment	(especially	with	a	doctor	
who	 has	 a	 personal	 relationship	 with	 the	 individual	
seeking	 attention)	 through	 to	 fears	 that	 the	GP	based	
approaches	 may,	 especially	 in	 contexts	 where	 there	
are	strong	demands	for	the	avoidance	of	‘unnecessary’	
diagnostic	 testing	 costs,	 undesirably	 slow	 access	 to	
timely	 specialist	 advice.	 Poor	 quality	 primary	 care	 can	
also	 discourage	 health	 service	 users	 from	 pro-actively	
seeking	to	protect	their	health,	and	so	add	to	long	term	
costs	and/or	health	loss.
Negative	 approaches	 to	 health	 care	 demand	
management	may	make	people	feel	that	they	should	not	
‘bother’	health	professionals	with	what	are	probably	minor	
problems,	but	could	 in	a	minority	of	 instances	be	early	
manifestations	of	serious	disease.	The	consequences	of	
such	phenomena	have	 included	not	only	 relatively	 low	
rates	of	early	stage	disease	diagnosis	 in	fields	such	as	
cancer	care,	but	a	more	widespread	neglect	of	 ‘trivial’	
health	 issues	 that	 can	 in	 some	 cases	 herald	 disability	
or	 life	 threatening	events	associated	with,	 for	example,	
underlying	vascular	disease.
There	is	some	evidence	of	such	failings	in	the	working	of	
other	strongly	GP	centred	health	care	systems,	like	that	
of	Denmark	(OECD,	2015).	As	noted	above,	there	have	
in	Britain	also	been	problems	relating	to	the	co-ordinated	
provision	 of	 primary	 medical	 care	 with	 other	 forms	 of	
community	 health	 and	 social	 service	 support.	 Such	
phenomena	 link	 in	part	 to	 the	 fact	 that	Local	Authority	
social	and	allied	care	provision	was	not	made	‘free at the 
point of demand’ in	 the	way	 that	access	 to	NHS	care	
was	guaranteed	after	the	end	of	World	War	II.
With	the	decline	of	infectious	disease	and	the	consequent	
rise	 of	 non-contagious	 disorders	 of	 later	 life	 the	 need	
for	 services	 that	 facilitate	 satisfactory	 independent	
living	 despite	 their	 users	 having	 to	 cope	 with	multiple	
morbidities	has	risen.	Compared	with	most	if	not	all	other	
health	care	systems	the	NHS	has	met	this	challenge	well,	
within	the	boundaries	of	the	resources	made	available	by	
successive	 governments	 (WHO,	 2015).	But	 even	 so	 it	
is	arguably	the	case	that	clinically	and	socially	desirable	
progress	could	have	been	achieved	faster.
The	existence	of	the	NHS	could	in	some	instances	have	
hidden	 ongoing	 failings	 in	 service	 areas	 that	 lack	 the	
social	standing	of	specialised	medicine.	The	creation	of	
a	universal	health	service	in	1940s	Britain	was	intended	
to	sweep	away	the	heritage	of	the	Victorian	Poor	Law.	
It	has	largely	achieved	this	goal	 in	fields	like	the	supply	
of	most	medicines	and	basic	access	to	doctors.	Yet	the	
record	of	 the	British	 system	 in	 supporting	people	with	
health	and	related	problems	associated	with	economic	
disadvantage	 and	 daily	 living	 difficulties	 does	 not	
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compare	as	well	as	might	sometimes	be	hoped	with	that	
of	EU	countries	like	The	Netherlands,	France,	Germany	
and	 Sweden.	 Such	 realities	 help	 to	 account	 for	 the	
relatively	modest	 ranking	of	 the	UK	on	scales	such	as	
the	European	Health	Consumer	Index	(EHCI,	2014),	and	
may	partially	explain	the	persistence	of	reducible	health	
inequalities	despite	the	‘welfare	State’.
Relationships and cultures that deliver better 
health
There	 is	 research	 showing	 that	 many	 people	 facing	
serious	 health	 challenges	 wish	 their	 GPs	 to	 be	 the	
primary	 co-ordinators	 of	 their	 treatment	 and	 support,	
and	that	most	GPs	wish	to	play	this	role	well	(Parsons	et	
al,	2010).	Yet	in	reality	the	ability	of	the	existing	NHS	and	
social	services	system	to	deliver	complex,	multi-faceted	
care	in	the	community	and	to	handle	transfers	between	
different	 hospital	 and	 other	 service	 providers	 in	 timely,	
convenient	and	‘user	friendly’	ways	is	often	limited.
GPs	 frequently	 report	 that	 they	 cannot	 always	 invest	
the	time	and	other	resources	needed	to	coordinate	the	
support	 required	 by	 vulnerable	 individuals.	 But	 many	
also	 seem	 unable	 or	 unwilling	 to	 pass	 this	 role	 on	 to	
colleagues	such	as	community	matrons	or	district	nurses	
in	a	timely	manner.	Similar	points	apply	in	contexts	like	
the	 management	 of	 vascular	 disease	 risks,	 and	 the	
extended	 part	 that	 professionals	 such	 as	 community	
pharmacists	could	play	in	this	and	allied	fields.
Such	 observations	 ought	 not	 to	 obscure	 the	 realities	
of	 service	 under-funding,	 as	 and	 when	 they	 exist.	
Nevertheless,	 there	 is	 a	 case	 for	 saying	 that	 General	
Practitioners	 and	 Community	 Pharmacists	 could,	
together	 with	 the	 other	 professional	 groups	 providing	
primary	 health	 and	 social	 care,	 in	 future	 do	 more	 to	
help	 improve	 the	 quality	 of	 services	 by	 overcoming	
sectional	concerns	and	strengthening	commitments	 to	
‘integrating’	 care	by	working	 together	more	 effectively.	
Regardless	 of	 structural	 issues	 or	 even	 financial	
incentives,	appropriate	ethical	 imperatives	are	essential	
for	the	delivery	of	adequately	coordinated	primary	care	in	
today’s	environment.
Some	critics	argue	that	GPs	tend	to	over-emphasise	the	
importance	 of	 services	 under	 their	 immediate	 control,	
and	 fail	 to	support	adequately	 the	development	of	 the	
primary	 care	 system	 as	 a	 whole.	 At	 the	 same	 time	
Community	Pharmacists	(CPs)	can	appear	–	at	least	to	
some	observers	–	to	be	unduly	concerned	with	processes	
of	drug	supply	which	may	not	be	optimally	cost	effective	
from	a	public	interest	perspective,	or	always	ideal	from	a	
consumer	convenience	viewpoint.
It	 may	 also	 be	 suggested	 that	 hospital	 oriented	
professionals	 and	 managers	 are	 on	 occasions	
inadequately	 informed	 about	 the	 role	 of	 primary	
care,	 and	 can	 fail	 to	 act	 in	 the	 best	 overall	 interests	
of	 the	 communities	 they	 serve	 because	 of	 an	 (albeit	
understandable)	 desire	 to	 defend	 ‘their’	 institutions	 as	
free-standing	entities	 in	competition	with	other	parts	of	
the	health	service.	Such	phenomena	might,	for	example,	
underpin	opposition	to	forms	of	primary	care	led	budget	
holding	 that	 their	 advocates	 believe	would	 allow	more	
flexible	and	better	managed	approaches	to	the	delivery	of	
NHS	patient	support	across	community	and	institutional	
boundaries.
Assuring	the	stability	and	sustainability	of	NHS	hospital	
services	is	important.	But	it	would	be	self-defeating	if	this	
were	to	be	pursued	in	ways	which	undermine	the	capacity	
of	the	health	service	to	offer	the	best	possible	care	with	
the	 global	 financial,	 technical	 and	 human	 resources	
available,	 and	make	 it	 needlessly	 difficult	 for	 desirable	
change	to	be	achieved.	Determining	the	‘right’	number	
of	hospital	beds	and	the	marginal	costs	and	benefits	of	
reducing	inpatient	care	capacity	or	other	forms	of	service	
at	any	one	point	in	time	is	a	complex	and	often	uncertain	
task.	But	long	term	progress	will	probably	require	relative	
increases	in	the	provision	of	the	full	range	of	community	
based	facilities,	alongside	continuing	adaptations	in	the	
configuration	of	specialist	services.
‘Pharmacy first’?
Against	the	above	background,	this	report	considers	the	
development	of	primary	care	in	the	context	of	the	NHS	
as	 a	 whole,	 and	 the	 changing	 health	 and	 social	 care	
related	needs	and	abilities	of	the	country’s	population.	In	
the	light	of	NHS	England’s	Five Year Forward View (the	
FYFV	–	NHS	England,	2014)	and	recent	initiatives	such	
as	the	National	Association	for	Primary	Care’s	support	for	
the	Primary	Care	Home	concept	(NAPC,	2015)	and	the	
joint	 NAPC/Royal	 Pharmaceutical	 Society	 consultation	
‘Improving patient care through better general practice 
and community pharmacy integration’ (NAPC	 and	 the	
RPS,	 2015),	 it	 considers	 aspects	 of	 the	 relationships	
between	 GPs,	 community	 pharmacists,	 community	
nurses	and	other	primary	care	providers.	It	also	explores	
how	further	improvements	in	their	collective	performance	
might	best	be	pursued.
Given	factors	such	as	emerging	IT	based	opportunities	
for	 enhancing	 processes	 like	 providing	 information,	
diagnosing	mental	and	physical	illnesses	and	prescribing	
and	 dispensing	 medicines,	 this	 analysis	 in	 addition	
addresses	 questions	 relating	 to	 how	 independently	
located	 community	 pharmacy	 services	 can	 contribute	
further	 to	 the	 promotion	 of	 self-care	 and	 provision	 of	
better	 co-ordinated	 and	more	 affordable	 primary	 care.	
Given	financial	pressures	and	 the	ongoing	 introduction	
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of	‘constructively	disruptive’	health	technologies	(EXPH,	
2015)	and	new	consumer	demands,	continuing	health	
sector	 change	 is	 inevitable.	 A	 fundamental	 challenge	
for	professionals	 like	GPs	and	community	pharmacists	
relates	to	the	extent	to	which	they	will	be	able	to	play	a	
positive	 role	 in	actively	shaping	new	models	of	service	
governance	and	delivery.
One	of	the	main	findings	of	this	report	is	that	the	existing	
community	pharmacy	network	 is	a	resource	that	could	
and	arguably	should	be	developed	in	ways	that	will	allow	
it	 to	go	on	supplying	medicines	 in	cost	effective	ways,	
while	also	offering	‘first	contact’	access	to	clinical	care	in	
the	community	in	a	progressively	more	efficient	manner.	
Failures	 to	 establish	 and	 implement	 a	 strong	 vision	
for	 Community	 Pharmacy	 alongside	 that	 for	 General	
Practice	 could	 threaten	 the	NHS	 as	 a	whole,	 and	 the	
interests	of	the	public	it	serves.
Future	 progress	 will	 almost	 certainly	 challenge	 the	
traditional	 demarcation	 lines	between	medical,	 nursing	
and	 pharmacy	 practice	 and	 weaken	 the	 borders	
between	 prevention	 and	 treatment,	 as	 well	 as	 those	
between	 professional	 support	 and	 self-care.	 Other	
developments	 in	 the	 organisation,	 management	 and	
delivery	 of	 professional	 services	 will	 also	 be	 needed,	
including	(probably	if	not	certainly)	increases	in	the	scale	
and	 complexity	 of	 primary	 or	 integrated	 primary	 and	
secondary	medical	care	organisations	and	their	capacity	
to	streamline	service	delivery.
However,	 as	 the	work	 of	 economists	 such	 as	 Joseph	
Schumpeter	 (1942)	 and	 Ernst	 Schumacher	 (1973)	
has	 in	 the	 past	 highlighted,	 the	 relationship	 between	
organisational	 size	 and	 variables	 such	 as	 innovation	
and	 personal	 service	 quality	 and	 satisfaction	 is	 not	
straightforward.	 Inadequately	 considered	 changes	 can	
have	 perverse	 results.	 There	 are	 costs	 to,	 as	 well	 as	
efficiencies	of,	increased	scale	that	should	be	balanced	
against	 the	 overall	 benefits	 provided	 for	 communities,	
individual	 service	 users	 and	 ‘hands	 on’	 providers.	 At	
worst,	creating	larger	organisations	can	serve	sectional	
managerial	ends,	as	distinct	from	public	interests	in	better	
access	to	personally	focused	professional	support.
From Medical Dominance to 
Managed Care?
The	formation	of	the	NHS	in	1948	was	partially	inspired	
by	 the	 Soviet	 Union’s	 pioneering	 attempts	 after	 1918	
to	 establish,	 in	 very	 much	 harder	 circumstances	 than	
those	facing	Britain	at	any	point	in	the	twentieth	century,	
a	 universal	 health	 care	 system.	 Yet	 the	 establishment	
of	 the	NHS	was	not	a	 ‘nationalisation of the means of 
health care production’	 like	 that	 of	 the	 railways	 and	
other	 key	utilities	undertaken	by	 the	Atlee	government	
during	Britain’s	 late	1940s	post-war	 recovery.	 Its	most	
prominent	 immediate	architect,	William	Beveridge,	was	
a	Liberal,	and	the	concept	of	universal	health	care	was	
strongly	 supported	by	Conservatives	 such	 as	Winston	
Churchill	and	Henry	Willinck,	England’s	wartime	Health	
Minister.	Aneurin	Bevan,	who	as	a	subsequent	Labour	
Minister	rejected	the	Bismarkian	social	insurance	model	
and	 favoured	 a	 tax	 funded	 National	 Health	 Service,	
described	 the	 creation	 of	 the	 health	 service	 as	 an	
example	of	 the	practical	application	of	Christian	values	
rather	than	as	an	achievement	of	secular	socialism.
Voluntary,	 private	 and	 previously	 Local	 Authority	 run	
institutions	 were	 taken	 into	 public	 ownership	 in	 1948	
and	combined	 to	 form	a	unified	NHS	hospital	 service.	
However,	the	Teaching	Hospitals	retained	a	special	self-
governing	 status,	 and	 the	 National	 Health	 Service	 as	
originally	 formed	 was	 a	 tripartite	 structure.	 It	 included	
practitioners	 such	 as	 GPs,	 community	 pharmacists,	
dentists	 and	 opticians	 who	 were	 independently	
contracted	 to	 the	 Minister	 of	 Health	 and	 who	 owned	
their	premises,	as	well	as	the	Local	Authority	controlled	
and	 funded	 district	 nursing,	 health	 visiting	 and	 public	
health	services.
These	community	based	resources	were	no	 less	a	part	
of	 the	 overall	 NHS	 system	 than	 the	 nationally	 owned	
hospitals,	 although	 the	 structure	 of	 the	 new	 service	
perpetuated	 the	 ‘gate	 keeping’	 divide	 between	 primary	
and	secondary	care	that	had	existed	in	British	medicine	
from	 the	 last	 decades	 of	 the	 nineteenth	 century.	 In	 the	
Community	 Pharmacy	 sector	 the	 new	 health	 service	
adopted	a	mixed	corporately	and	individually	owned	retail	
model	that	had	also	emerged	in	the	late	Victorian	era.
In	its	initial	decades	the	NHS	was	not	strongly	managed	
by	individuals	other	than	health	professionals,	amongst	
whom	 the	 medical	 profession	 was	 indisputably	
dominant.	 Further,	 its	 financial	 resources	 were	 in	 the	
main	 allocated	 on	 an	 incremental	 basis,	 rather	 than	
via	 either	 a	 competitive	 or	 a	 robustly	 supported	 ‘non-
market’	process.	Most	of	the	reforms	introduced	in	the	
last	60-70	years	can	be	seen	as	attempts	to	better	plan,	
manage	and	co-ordinate	care	provision	offered	by	either	
the	NHS	alone,	or	by	the	NHS	and	Local	Authorities	in	
combination.	The	time	line	offered	in	Figure	3	highlights	
some	 of	 the	major	 steps	 involved	 in	 the	 development	
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Figure 3. The Evolution of the NHS in England – an Outline Timeline
1942-46 Sir	William	Beveridge’s	report	Social Insurance and 
Allied Services proposed	the	creation	of	the	modern	
welfare	State	and	the	establishment	of	the	NHS	in	
1942,	although	the	concept	of	a	National	Health	
Service	dates	back	to	1910.	A	White	Paper	was	
published	by	the	wartime	coalition	government	in	
1944	and	the	NHS	Act	was	passed	in	1946,	a	year	
after	Aneurin	Bevan	became	Minister	for	Health.
1948 The	NHS	is	established	with	the	opening	of	Park	
Hospital	in	Manchester
1949 The	Nurses	Act	sought	to	establish	a	new	basis	for	
nursing,	and	concerns	about	the	affordability	of	the	
NHS	were	expressed.	
1950-56 JS	Collings	found	that	‘the overall state of general 
practice is bad and still deteriorating’.	A	one	shilling	
prescription	charge	was	first	levied	in	1952,	and	
initial	attempts	are	made	to	promote	the	formation	of	
group	practices.	In	1956	the	Guillebaud	Inquiry	found	
that	the	NHS	was	affordable	and	that	there	was	no	
evidence	that	its	establishment	had	led	to	extravagant	
health	care	spending.
1962 Enoch	Powell	launches	a	plan	involving	the	
establishment	of	district	general	hospitals	serving	local	
populations	of	about	125,000	people
1966 The	‘Doctor’s	Charter’	introduces	new	incentives	for	
the	development	of	better	staffed	GP	practices
1974 The	first	major	NHS	reorganisation	seeks	to	put	
in	place	a	unitary	structure	involving	90	Health	
Authorities	in	England	and	14	Regional	Health	
Authorities.	However,	the	Executive	Councils	that	
previously	administered	family	practitioners	services	
are	replaced	by	Family	Practitioner	Committees	that	
continued	to	function	in	relative	isolation.	Community	
Health	Councils	were	created.	They	enjoyed	a	
significant	degree	of	critical	autonomy.	Functions	such	
as	district	nursing	and	public	health	are	removed	from	
local	government,	but	social	service	provision	remains	
under	LA	control	and	is	in	health	context	subject	to	
charges
1976 Sharing Resources for Health in England signals	a	
new	approach	to	NHS	resource	allocation
1983 The	Griffiths	Report	marked	the	introduction	of	general	
management	in	the	NHS,	although	its	impact	on	
primary	care	development	is	relatively	limited
1986 Neighbourhood Nursing: a Focus for Care and	the	
Nuffield	report	Pharmacy	raise	important	questions	
about	the	future	of	community	nursing	and	community	
pharmacy.	However,	progress	towards	more	effectively	
coordinated	service	provision	remains	limited.
1989-91 Following	an	intervention	by	Margaret	Thatcher,	the	
White	Papers	Working for Patients and	Caring for 
People	lead	to	the	1990	NHS	and	Community	Care	
Act.	The	NHS	internal	market	with	GP	Fundholding	
and	more	autonomous	hospital	Trusts	at	its	centre	
was	established	in	1991.
1997 Tony	Blair’s	new	labour	government	moves	rapidly	
to	end	GP	Fundholding	and	the	White	Paper	The 
New NHS: Modern, Dependable	promises	a	non-
market	approach	based	on	collaboration	rather	
than	competition.	It	also	opens	the	way	to	the	
establishment	of	NICE	and	what	is	today	the	CQC
1999 The	short	lived	but	relatively	popular	Primary	Care	
Groups	(PCGs)	were	set	up
2000-02 The	NHS	Plan	is	published,	with	proposed	hospital	
service	improvements	to	be	financed	via	the	Private	
Finance	Initiative.	NHS	funding	growth	is	accelerated,	
and	Primary	Care	Trusts	replace	PCGs	with	the	
intention	of	further	developing	the	utility	of	the	NHS	
purchaser	provider	divide.	Secretary	of	State	Alan	
Milburn	announced	plans	to	introduce	Foundation	
Trusts	in	2002,	and	potentially	‘awkward’	CHCs	were	
abolished	in	2003	
2006-
2009
Our Health, Our Care, Our Say: a new direction 
for community services seeks	to	promote	the	
development	of	better	coordinated	primary	health	and	
social	care.	The	RCGP	first	proposes	the	formation	
of	GP	Federations	and	Lord	Darzi	subsequently	leads	
a	review	calling	for	greater	service	integration	and	
increased	clinician	involvement	in	health	care	quality	
management
2010-12 The	new	coalition	government	publishes	Equity and 
Excellence – Liberating the NHS	which	leads	on	to	
the	2012	Health	and	Social	Care	Act.	This	involves	
the	abolition	of	PCTs	and	the	formation	of	Clinical	
Commissioning	Groups	(CCGs)	as	well	as	a	range	of	
other	innovations,	including	the	establishment	of	NHS	
England	and	Public	Health	England	
2013 Sir	Robert	Francis	presents	the	final	report	of	the	Mid-
Staffordshire	NHS	Foundation	Trust	Public	Inquiry
2014 The	Five	Year	Forward	View	(FYFV)	sets	out	NHS	
England’s	strategic	approach	to	questions	such	as	
reducing	health	inequalities,	improving	care	quality	
and	meeting	projected	health	and	social	care	funding	
shortfalls.	It	highlights	the	potential	role	of	new	care	
providers	such	as	multispecialty	community	providers	
(MCPs)	and	primary	and	acute	care	systems	(PACs)	
perhaps	run	along	lines	parallel	to	those	developed	by	
US	accountable	care	providers.
2015 The	National	association	for	Primary	Care	publishes	
its	‘Primary	Care	Home’	proposals,	and	the	NAPC	
and	the	Royal	Pharmaceutical	Society	conduct	a	joint	
consultation	on	closer	working	between	community	
pharmacies	and	general	practices.	NHS	England	
announces	support	for	the	employment	of	more	
pharmacists	in	practices,	but	it	becomes	clear	that	
the	cap	on	private	social	care	costs	proposed	by	the	
Dilnot	Commission	in	2011	will	not	be	implemented	in	
the	foreseeable	future	and	that	an	increasing	crisis	in	
local	authority	funded	social	care	provision	is	putting	
increasingly	severe	pressures	on	NHS	Trust	finances.	
The	November	2015	Comprehensive	Spending	
Review	led	to	the	announcement	of	increased	
freedoms	for	English	local	authorities	to	fund	social	
care	via	raised	Council	taxes.	An	NHS	budget	
increase	of	£4	billion	was	also	announced,	in	line	with	
NHS	England	requests.
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of	primary	care	within	the	wider	evolution	of	 the	health	
service	in	England.
The	 British	 Medical	 Association	 originally	 opposed	
the	 creation	 of	 the	 NHS,	 along	 with	 sections	 of	 the	
national	 press.	 Some	 doctors’	 representatives	 feared	
an	 undermining	 of	 medical	 authority	 and	 income.	 Yet	
following	 the	 establishment	 of	 the	 new	 health	 service	
doctors	 found	 themselves	 able	 to	 retain	 substantive	
control	over	their	work,	and	hence	to	play	a	central	role	
in	directing	the	use	of	its	publicly	provided	funds.	At	the	
same	time	the	ability	of	specialist	elites	within	medicine	
to,	 especially	 in	 London,	 accrue	 additional	 private	
income	remained	intact.
Even	in	the	1960s	Health	Ministers	such	as	Enoch	Powell	
could	set	policy	at	a	strategic	level	in	relation	to	matters	
such	as	the	configuration	of	hospital	care,	yet	had	little	
impact	on	the	conduct	of	day-to-day	professional	work.	
Hospital	doctors	were	contracted	to	regional	authorities	
rather	 than	 the	 institutions	 in	which	 they	worked.	GPs	
were	 individually	 contracted	 to	 the	 Minister	 of	 Health,	
albeit	their	day-to-day	accountabilities	for	service	quality	
were	 in	 the	main	 to	 their	professional	bodies	and	 to	a	
lesser	 extent	 to	 the	 Executive	 Councils	 that	 at	 that	
time	administered	 their	 payments,	 along	with	 those	 to	
community	pharmacies,	dentists	and	opticians.
This	period	has	–	particularly	in	relation	to	hospital	care	–	
been	described	as	one	of	‘medical	dominance’,	and	as	
a	‘golden	age’	for	medicine	(Burnham,	1982;	McKinlay	
and	Marceau,	2002).	NHS	patients	no	longer	had	direct	
‘power	of	purse’	over	 those	providing	 them	with	care,	
while	non-clinician	 led	health	service	management	had	
yet	 to	 emerge	 in	 its	 modern	 form.	 Doctors	 decided,	
patients	complied	and	tax	payers	paid.	Notwithstanding	
funding	system	variations,	much	the	same	state	of	affairs	
existed	in	other	countries	at	that	time,	including	the	US	
(Freidson,	1970a,	1970b).
However,	this	situation	began	to	change	in	the	UK	with	
the	 first	 major	 NHS	 reorganisation	 in	 1974	 and	 the	
subsequent	 introduction	 during	 Margaret	 Thatcher’s	
premiership	 of	 (following	 the	 1983	 ‘Griffiths	 Report’)	
general	 management	 and	 the	 NHS	 ‘internal	 market’.	
It	 was	 also	 at	 the	 start	 of	 the	 1980s	 that	 the	 then	
Health	 Minister	 Dr	 Gerard	 Vaughn	 began	 questioning	
the	 prescription	 medicines	 supply	 rather	 than	 patient	
care	focused	role	of	NHS	community	pharmacists	that	
emerged	from	the	end	of	the	1940s.
Hospital	 pharmacy	 began	 to	 take	 a	 more	 pro-active	
clinical	–	or	at	least	drug	safety	oriented	–	role	in	the	wake	
of	the	Thalidomide	tragedy	at	the	start	of	the	1960s.	But	
NHS	 Community	 Pharmacy	 had	 become	 increasingly	
centred	on	high	volume	prescription	medicines	supply.	
At	the	1981	British	Pharmaceutical	Conference	Vaughn	
commented	 ‘one knew there was a future for hospital 
pharmacists, one knew there was a future for industrial 
pharmacists, but one was not sure that one knew the 
future for the general practice [community] pharmacist’	
(Anderson,	2007).	This	 intervention	 led	to	a	process	of	
role	reassessment	which	has	continued	through	to	the	
present	day.
GP Fund-holding
GP	 Fund-holding	 was	 first	 established	 in	 1991.	 The	
National	Health	Service	and	Community	Care	Act	1990	
also	created	more	independent	Hospital	Trusts,	governed	
by	 chief	 executives	 and	Boards	 and	 to	which	medical	
consultants	 were	 for	 the	 first	 time	 directly	 contracted.	
NHS	Trusts	over	time	became	more	like	private	‘for	profit’	
institutions.	 As	 the	 NHS	 record	 on	 service	 integration	
and	 the	care	quality	problems	 revealed	by	 the	Francis	
Inquiry	 (2013)	 indicate,	 this	 approach	 has	 had	 mixed	
outcomes	(Lester,	2015).	While	many	aspects	of	service	
provision	have	been	improved	by	the	non-medical	NHS	
managerialism	that	has	evolved	since	the	1980s,	failures	
have	on	occasions	harmed	care	quality.	The	1990	Act	
may	 also	 have	 exacerbated	 aspects	 of	 the	 NHS	 and	
social	 care	 funding	 divide,	 so	 perhaps	 creating	 new	
incentives	 to	 cut	 back	 in	 areas	 like	 NHS	 community	
nursing.
Both	GP	Fund-holding	and	NHS	Trusts	were	central	to	
forming	 a	 more	 market-like	 system	 of	 NHS	 resource	
distribution	and	service	delivery.	However,	thanks	in	part	
to	the	demands	of	competition	law	and	the	questionably	
logical	 continuation	 of	 the	 NHS	 ‘purchaser-provider	
divide’	 after	 GP	 Fund-holding	 was	 abandoned,	 the	
costly,	 complex	 and	 highly	 bureaucratised	 manner	 in	
which	 NHS	 ‘internal	market’	 contracting	 subsequently	
developed	 was	 not	 in	 line	 with	 its	 early	 advocates’	
intentions.	 Money	 was	 supposed	 to	 ‘follow	 patients’,	
whose	care	was	intended	to	be	increasingly	tailored	to	
their	 personal	 needs.	 But	 in	 reality,	 critics	 argue,	 care	
patterns	 became	 determined	 by	 rigid	 contracts	 and	 a	
purchasing/commissioning	 process	 that	 tended	 to	 be	
centered	 on	 cost	 control	 and	 basic	 standard	 setting	
rather	than	creative	quality	improvement	(Box	3).
Up	until	the	end	of	the	1980s	GPs	could	refer	patients	
more	or	less	freely	to	the	hospital	care	providers	of	their	
choice.	Yet	 the	adequacy	of	 the	mechanisms	that	had	
evolved	for	compensating	hospitals	 for	changing	 levels	
of	 service	 use	 was	 limited,	 and	 there	 were	 also	 fears	
that	 general	 practitioners	 had	 inadequate	 incentive	 to	
keep	 people	 out	 of	 hospital	when	 their	 care	 could	 be	
better	 provided	 at	 the	 practice	 level	 or	 in	 other	 less	
costly	settings.	Fund-holding	was	 intended	 to	address	
both	 these	problems,	 in	part	by	encouraging	GPs	and	
their	practice	colleagues	to	adopt	a	pro-active	‘make	or	
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buy’	 approach	 to	 supplying	 services	 for	 their	 practice	
populations.2
A	 variety	 of	 alternative	 solutions	 to	 resolving	 these	
problems	might	have	been	selected	at	 the	start	of	 the	
1990s.	 For	 example,	 a	 non-market	 approach	 could	
(in	 some	 ways	 like	 the	 Scottish	 NHS	 system	 today)	
have	 involved	 improving	 systems	 for	 monitoring	 and	
evaluating	professionally	determined	GP	referral	patterns	
and	 adjusting	 centrally	 directed	 hospital	 resource	
allocations	 to	 reflect	 local	 preferences	 and	 national	
service	improvement	priorities.
However,	 one	 positive	 effect	 of	 the	 seven	 year	 GP	
Fund-holding	 ‘experiment’	 that	 took	place	 in	England	
between	 1991	 and	 1998	was	 that	 the	 practices	 that	
successfully	 took	 part	 in	 it	 (along	 with	 the	 ‘multi-
funds’	 and	 ‘total	 purchasing	 pilots’	 that	 emerged)	
demonstrated	–	at	least	within	the	primary	care	arena,	
if	 not	 so	 clearly	 in	 the	 hospital	 sector	 –	 the	 potential	
of	 devolved	 GP	 led	 ‘purchasing’	 to	 deliver	 desirable	
service	improvements	in	relatively	brief	periods	of	time.	
2	 Both	during	the	GP	Fund-holding	era	and	subsequently	in	the	
case	of	CCG	commissioning	GPs	have	on	occasions	been	
accused	of	improperly	‘paying	themselves’	to	provide	additional	
services	to	their	populations,	sometimes	by	or	on	behalf	of	
interests	seeking	to	secure	increased	earnings	for	their	own	
companies	or	Trusts.	But	provided	all	interests	are	properly	
declared	and	decisions	are	at	due	points	audited	to	ensure	
probity	and	cost	effectiveness,	this	is	what	‘ACO	type’	local	
budget	holding	is	intended	to	achieve.	Where	it	is	cheaper	and	
better	primary	care	providers	should	‘make’	services	themselves.	
In	other	circumstances	they	should	buy	them	from	others	as	
efficiently	as	possible.	
Fund-holding	by	a	practice	or	practices	was	 found	at	
the	 time	 to	 incentivise	 the	 imaginative	 use	 of	 money	
that	was	not	tied	to	particular	disease	or	care	groups	
for	the	benefit	of	the	individuals	and	entire	populations.	
(See,	 for	 instance,	 le	Grand	et	al,	1998;	Brereton	and	
Vasoodaven,	2010).
Yet	 despite	 its	 positive	 dimensions,	 GP	 Fund-holding	
was	unpopular	with	the	then	Labour	opposition	and	with	
the	BMA,	as	well	as	with	sections	of	the	GP	community	
itself.	 It	 is	 sometimes	 claimed	 that	 Fund-holding	
divided	 General	 Practice,	 albeit	 in	 reality	 it	 can	 more	
accurately	be	said	that	it	revealed	important	differences	
in	 leadership	 and	 care	 delivery	 capacities	 that	 already	
existed.	 In	 addition,	 some	hospital	 staff	members	 and	
NHS	 managers	 involved	 in	 the	 nascent	 process	 of	
institutionalised	(contract	bound)	commissioning	saw	GP	
Fund-holding	as	a	threat.	It	was	consequently	abandoned	
soon	after	the	start	of	the	first	Blair	administration,	which	
was	elected	to	power	in	1997.
Opponents	 of	 what	 was	 sometimes	 termed	 ‘NHS	
marketisation’	welcomed	 this	step.	Yet	 it	was	 followed	
by	 a	 series	 of	 other	 attempts	 to	 harness	 market-like	
mechanisms	within	the	health	service.	These	eventually	
led	 to	 the	 establishment	 of	 Primary	 Care	 Trusts	
(PCTs),	and	 initiatives	 intended	to	develop	 ‘world	class	
commissioning’	 skills	 and	 to	promote	 the	 formation	of	
Foundation	Trusts.	This	seemingly	relentless	process	of	
change	was,	it	has	often	been	claimed,	responsible	for	
Box 3. Quality Management
The	history	of	‘quality	management’	dates	back	over	a	
century,	to	work	like	that	of	the	American	Frederick	Taylor	
and	the	conversion	of	craft	work	to	mechanised	factory	
production.	This	was	followed	by	the	contributions	of	
pioneers	 like	 Walter	 Shewhart	 of	 the	 Bell	 Telephone	
Company	on	process	quality	control,	and	subsequently	
that	of	post	World	War	II	‘quality	gurus’	such	as	William	
Edwards	 Deming,	 Joseph	 Duran,	 Kaoru	 Ishikawa,	
Shigeo	Shingo	and	Tom	Peters.
Such	commentators	introduced	concepts	ranging	from	
the	need	to	 ‘drive	out	 fear’	 in	 ‘learning	organisations’	
(based	 on	 the	 belief	 that	most	 people	 want	 to	 do	 a	
good	 job,	 and	 that	 performance	 monitoring	 and	
feedback	 should	 therefore	 be	 supportive	 rather	
than	 punitive)	 through	 to	 ‘just	 in	 time	 delivery’,	 ‘total	
quality	 management’,	 ‘continuous	 performance	
improvement’,	 ‘business	process	 re-engineering’	 and	
‘transformational	leadership’.
Well	 known	 examples	 of	 attempts	 to	 apply	 such	
thinking	in	health	care	range	from	the	work	of	Florence	
Nightingale	 during	 and	 after	 the	 Crimean	 War	 to,	 in	
the	 twentieth	 century,	 the	 contributions	 of	 Dr	 Avedis	
Donabedian	 and	 more	 recently	 those	 of	 Dr	 Don	
Berwick.	 The	 creation	 of	 bodies	 such	 as	 NICE	 and	
what	is	now	the	CQC	stemmed	from	attempts	to	apply	
‘quality	management’	concepts	 to	 the	 running	of	 the	
NHS.
For	the	purposes	of	this	analysis	two	points	are	worth	
special	emphasis.	First,	although	quality	management	
techniques	can	release	savings	through,	 for	 instance,	
reducing	 waste	 associated	 with	 redundant	 activities	
and	 concentrating	 effort	 on	 meeting	 external	 and	
internal	 ‘customers’	 highest	 priority	 requirements,	
there	 is	 robust	 evidence	 that	 if	 cost	 saving	becomes	
a	primary	goal	this	often	results	in	aspects	of	product	
and	service	quality	being	undermined.
Second,	 actions	 which	 devalue	 the	 status	 and	
undermine	 the	motivation	 of	workers	 are	 in	 any	 field	
likely	 to	 have	 similar	 detrimental	 consequences.	 In	
health	 and	 social	 care	 systems	 good	 management	
is	 essential.	 But	 over-management	 is	 dangerous.	 If	
managers	come	to	see	themselves	and	their	inevitably	
sectional	 objectives	 as	 more	 important	 than	 people	
using	 health	 and	 social	 services	 or	 more	 legitimate	
than	the	professional	goals	of	and	 judgements	of	 the	
clinicians	 and	 other	 individuals	 delivering	 care,	 their	
efforts	 will	 almost	 certainly	 have	 counter-productive	
consequences.
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undermining	GP	and	wider	health	sector	morale	during	
the	first	decade	of	the	current	century.
‘Serial	 change’	 was	 commonly	 experienced	 as	
disruptive	 and	 lacking	 adequate	 justification.	 But	
alongside	these	structural	changes,	NHS	funding	was	
dramatically	increased	in	the	first	decade	of	the	twenty	
first	 century	 (Figure	 4).	 Public	 satisfaction	 with	 the	
NHS	rose	in	line	with	better	resourcing,	that	gradually	
took	 NHS	 funding	 as	 measured	 by	 the	 proportion	
of	GDP	devoted	 to	health	close	 to	 the	OECD	mean.	
This	 allowed	 improved	 service	 quality,	 as	 indicated	
by	measures	 like	 reduced	 waiting	 times	 for	 hospital	
care.	 Developments	 were	 also	 introduced	 in	 areas	
such	as	community	pharmacy.	These	took	the	shape	
of	 services	 like	 ‘minor’	 ailment	 treatment	 schemes,	
pharmacist	 led	 repeat	 dispensing	 arrangements	 and	
Medicines	Use	Reviews	(MURs).
However,	there	is	no	evidence	that	such	innovations	have	
–	although	useful	 –	 to	date	 fundamentally	 transformed	
primary	 care	 performance.	 It	 can	 be	 argued	 that	 after	
the	 formation	 of	 PCTs	 the	 extent	 to	 which	 local	 GPs	
and	 other	 primary	 health	 care	 professionals	were	 able	
to	play	effective	 local	roles	 in	finding	and	implementing	
radically	better	ways	of	meeting	changing	health	needs	
was	 in	 fact	diminished.3	Some	PCTs	were	regarded	as	
successful.	But	others	were	seen	as	lacking	the	insight	
and	 capabilities	 needed	 to	 promote	 better	 service	
provision	through	commissioning.
3	 It	is	also	of	note	that	during	the	first	Blair	administration	decisions	
were	made	both	to	replace	the	by	then	well-established	
Community	Health	Councils	(that	had	originally	been	created	via	
1974	NHS	reorganisation)	and	to	stop	regular	contact	between	
NHS	Trust	and	Authority	chairpersons	and	the	then	Secretary	of	
State.	Although	presented	in	ways	that	suggested	a	concern	for	
NHS	democratisation	and	consumer	empowerment,	such	actions	
might	also	be	considered	consistent	with	a	desire	to	impede	more	
forceful	‘bottom-up’	policy	challenges.
The	 coalition	 government	 elected	 in	 2010	 was	 not	
initially	 expected	 to	 introduce	 further	 major	 structural	
changes	 in	 the	 NHS.	 Hence	 the	 far	 reaching	 reform	
plans	published	later	that	year	in	the	English	White	Paper	
Equity and Excellence: Liberating the NHS	 were	 for	
many	a	shock.	The	new	arrangements	eventually	set	out	
in	the	2012	Health	and	Social	Care	Act	(that	came	into	
full	effect	in	England	in	April	2013)	were	intended	by	the	
then	Conservative	Secretary	of	State	for	Health,	Andrew	
Lansley,	 to	provide	definitive	solutions	 to	 the	problems	
faced	 by	 the	 NHS.	 Yet	 regardless	 of	 their	 theoretical	
strengths	and	weaknesses	their	implementation	ran	into	
a	variety	of	difficulties.
It	 would	 be	 beyond	 the	 scope	 of	 this	 brief	 outline	
to	 attempt	 to	 describe	 in	 detail	 the	 development	 of	
the	 NHS	 in	 the	 last	 two	 to	 three	 years.	 However,	 the	
remainder	 of	 this	 section	 offers	 observations	 relating	
to	 the	ongoing	evolution	of	 the	primary	care	system	 in	
England,	with	special	relevance	to	general	medical	and	
pharmaceutical	 care	 and	providing	 community	 nursing	
and	social	services.
Health service spending
Total	UK	NHS	funding	rose	from	3.5	per	cent	of	GDP	in	
1949	to	about	8.5	per	cent	of	GDP	 in	2013/14.	There	
was	as	already	described	particularly	rapid	growth	in	the	
period	between	the	end	of	the	1990s	and	2009.	Since	
then	NHS	 outlays	 have	 slightly	 fallen	 as	 a	 percentage	
of	 total	 national	 resources,	 although	 in	 2016	 they	
should	 recover	 again	 following	 recently	 (November	
2015)	announced	increases	in	health	service	funding	in	
England.	At	the	same	time	overall	 local	authority	social	
care	spending	–	which	broadly	accounts	for	an	additional	
1	per	cent	of	GDP	–	has	reduced	since	2008-09.
Health	 and	 Social	 Care	 Information	 Centre	 estimates	
(HSCIC,	2015c)	indicate	that	outlays	on	adult	social	care	
for	the	population	aged	over	65	will	have	dropped	in	real	
terms	by	about	15	per	cent	between	then	and	2015/16.	
This	trend	has	increased	pressures	on	the	NHS.	In	future	
the	ability	of	Local	Authorities	to	increase	local	community	
charge	 payments	 to	 help	 fund	 enhanced	 social	 care	
should	help	stop	this	decline.	However,	this	alone	unlikely	
to	restore	such	provisions	to	past	levels,	let	alone	to	match	
Scandinavian	public	investments	in	care	for	groups	such	
as	mentally	and	physically	frail	older	people.4
Within	the	health	sector	total,	FHS/primary	care	spending	
fell	 from	around	 a	 third	 of	 all	NHS	costs	 in	 the	 1950s	
to	about	a	fifth	today.	This	has	in	part	been	because	of	
increased	 private	 payments	 for	 ophthalmic	 and	 dental	
services,	and	also	because	of	relative	falls	in	community	
4	 Current	negotiations	between	central	and	local	government	may	
also	be	touching	on	issues	such	as	the	extent	of	LA	land	holdings,	
and	the	degree	to	which	such	capital	assets	should	be	used	to	
fund	current	outlays	in	areas	such	as	residential	and	other	social	
care	provision.
Figure 4: NHS Funding Growth
Real	NHS	net	spend	1970	–	2010
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Note: real NHS funding in England grew by 5 per cent in the period 
between 2010 and 2015, which is a similar rate to that recorded for 
the NHS as a whole in the first half of the 1980s and above that in the 
second half of the 1970s. Recently announced expenditure increases 
in England mean that NHS funding will ultimately grow by 15-20% in 
real terms in the decade 2010-2020.
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pharmaceutical	costs	associated	with	the	genericisation	
of	many	commonly	dispensed	medicines	(Figure	5).
General	Medical	Service	(GMS)	costs	currently	represent	
about	8	per	cent	of	all	NHS	spending,	or	about	0.7	per	
cent	of	GDP.	The	proportion	of	NHS	funds	devoted	 to	
the	 GMS	 has	 declined	 as	 compared	 with	 five	 to	 ten	
years	ago	(it	stood	at	around	10	per	cent	of	NHS	costs	
in	2004/5),	albeit	the	General	Practice	workforce	is	larger	
than	at	any	previous	time.	Bodies	such	as	the	RCGP	and	
the	NAPC	have	recently	called	for	spending	on	general	
medical	 care	 to	 be	 increased	 to	 11	 per	 cent	 of	 NHS	
costs.	 Spending	 on	 General	 Pharmaceutical	 Services	
net	of	drug	costs	currently	represents	a	 little	under	2.5	
per	cent	of	all	NHS	outlays.
Public	debate	about	the	extent	to	which	health	service	
spending	 should	be	 increased	each	 year	 in	 real	 terms	
to	meet	rising	costs	can	be	confused	by	failures	to	take	
into	 account	 variables	 like	 the	 impacts	 of	 increased	
wages,	as	opposed	to	those	stemming	from	changes	in	
demand	for	care	and	expenses	incurred	as	a	result	of	the	
introduction	of	new	medical	technologies.	However,	it	is	
worth	highlighting	the	fact	that	health	service	and	allied	
spending	 in	 the	UK	 remains	below	 the	OECD	average	
when	expressed	as	a	percentage	of	GDP.	It	now	stands	
at	close	to	half	 the	proportion	of	GDP	spent	on	health	
in	the	US	and	around	three	quarters	of	that	recorded	in	
Germany,	France	and	The	Netherlands.
While	‘higher’	professional	salaries	such	as	those	for	GPs	
and	 hospital	 consultants	 in	 the	 UK	 compare	 reasonably	
well	 with	 reported	Western	 European	 earnings,	 the	 total	
numbers	 of	 doctors	 and	 pharmacists	 employed	 by	 the	
NHS	are	relatively	low	as	compared	with	the	levels	reported	
in	countries	like	Spain,	France	and	Germany.	At	the	same	
time,	spending	on	social	care	in	countries	like	Sweden	and	
the	Netherlands	is	over	3	per	cent	of	GDP,	 in	addition	to	
their	health	care	outlays.	This	further	increases	the	overall	
difference	 between	 health	 and	 social	 care	 spending	 in	
England	and	other	parts	of	the	UK	as	compared	with	that	
in	other	more	highly	developed	nations.
The	NHS	remains	in	global	terms	one	of	the	world’s	best	
resourced	and	run	health	care	systems.	Yet	the	fact	that	
it	pioneered	service	delivery	that	 is	still	 in	the	main	free	
at	the	point	of	demand	and	funded	by	general	taxation	
rather	than	social	insurance	appears	to	have	promoted	
policies	 that	 have	 over	 the	 long	 run	been	more	 tightly	
focused	on	cost	control	than	those	judged	appropriate	
in	other	more	affluent	countries.	The	UK	system	today	
is	 more	 centralised	 and	 politicised	 than	 alternative	
social	 insurance	 based	 health	 care	 models	 in	 other	
parts	of	Europe.	This	could	have	offset	the	advantages	
associated	with	 the	 fact	 that	 tax	 funding	 is	cheaper	 to	
raise	 than	 financing	 gathered	 via	 competing	 insurance	
schemes.
This	situation	may	or	may	not	have	disadvantaged	the	
British	population	 to	date.	But	 from	 the	perspective	of	
ensuring	 the	 future	quality	of	primary	health	and	social	
care	it	is	important	for	such	trends	to	be	well	understood.	
Otherwise	electoral	and	governmental	choices	might	be	
distorted	by	exaggerated	perceptions	of	the	cost	of	the	
NHS	or	 the	 supposed	generosity	 of	 the	 health	 related	
welfare	benefits	available	in	the	UK	as	opposed	to	other	
parts	of	the	EU.
The impacts of population ageing
In	1948	there	were	5	million	British	people	aged	65	and	
over,	 out	 of	 a	 total	UK	population	of	 about	 50	million.	
Of	 that	 5	million,	 only	 about	 200,000	 individuals	were	
aged	85	or	 over.	Average	 life	 expectancy	at	 birth	was	
68	years,	and	 for	people	aged	65	 it	was	a	 little	under	
14	years.	Today,	by	contrast,	 there	are	over	11	million	
aged	over	65	out	of	a	total	population	of	some	64	million	
(Figure	6).	About	1.5	million	people	 in	 the	UK	are	now	
aged	85	years	and	over,	and	this	number	will	more	than	
double	in	the	next	twenty	years.	Average	life	expectancy	
at	birth	for	males	and	females	combined	is	just	over	80	
years.	At	age	65	it	is	now	21	years.
Such	advances	in	survival	are	in	part	attributable	to	the	
success	of	 the	NHS,	and	 in	particular	 to	 reductions	 in	
infectious	and	cardiovascular	disease	mortality	 in	child,	
‘working	 age’	 and	 early	 later	 adult	 life.	 However,	 it	 is	
often	 (incorrectly)	 claimed	 by	 political	 and	 professional	
commentators	alike	that	population	ageing	has	been	the	
main	driver	of	increased	health	care	costs	and	that	it	will	
in	future	threaten	the	financial	viability	of	health	services	
as	currently	constituted	in	this	country	and	elsewhere	in	
the	world.
It	is	true	that	population	ageing	is	changing	the	balance	
of	hospital	and	primary	health	and	social	care	workloads	
–	health	care	systems	need	to	adjust	to	accommodate	
this	and	associated	trends	(WHO,	2015).	 It	 is	also	true	
that	at	any	given	point	in	time	older	adults	are,	outside	
the	 field	 of	 maternity	 services,	 likely	 to	 require	 more	
health	care	than	younger	ones.	Yet	it	is	not	the	case	that,	
Figure 5: Cost of Family Health Services (FHS) 
at 2010/11 prices, UK, 1950/51 - 2010/11
Source:	Hawe	and	Cockcroft,	2013
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to	date	at	 least,	population	ageing	has	by	itself	been	a	
major	driver	of	increased	total	spending.
The	best	available	evidence	indicates	only	about	0.2	per	
cent	of	the	3-4	per	cent	average	annual	increase	in	NHS	
costs	seen	in	past	decades	was	due	to	this	cause	per 
se.	In	future	decades	the	yearly	extra	spending	on	health	
care	 needed	 because	 of	 the	 impacts	 of	 population	
ageing	may	rise	to	about	1	per	cent	of	total	NHS	outlays.	
Yet	this	will	not	be	an	unmanageable	problem,	especially	
if	better	primary	care	 led	case	management	strategies	
prove	able	to	mitigate	the	cost	impacts	associated	with	
rising	 absolute	 (as	 distinct	 from	 age	 specific)	 rates	 of	
long	term	ill-health	and	multi-morbidity.
The	 future	 challenges	 associated	 with	 ageing	 in	 this	
country	 are	 substantially	 less	 than	 those	 now	 facing	
nations	 like,	 for	 instance,	 China	 or	 Iran,	 which	 are	
entering	into	a	much	more	rapid	period	of	change	in	their	
population	 structures	 than	 that	 being	 experienced	 in	
Western	Europe.	The	benefits	of	increased	longevity	and	
healthy	 life	 expectancy	 achieved	 in	 the	 last	 century	 or	
so	significantly	outweigh	any	costs	that	can	reasonably	
be	attributed	 to	extended	survival.	This	 is	 in	 large	part	
because	as	death	is	postponed,	so	too	are	the	costs	of	
end	of	life	care	and	to	varying	degrees	those	associated	
with	having	to	live	with	disability.
If	 healthy	 life	 expectancy	 can	be	 extended	 in	 line	with	
overall	 life	 expectancy	 gains,	 the	 net	 economic	 costs	
of	 such	 progress	 could	 prove	 negative.	 However,	 this	
is	 not	 to	 deny	 that	 population	 ageing	 will	 over	 time	
require	 greater	 investment	 in	 preventive	 services	 and	
effectively	coordinated	health	and	social	care	provision	
in	 the	 community.	 It	 is	 once	 again	 important	 from	 the	
perspective	of	assuring	the	fitness	for	purpose	of	primary	
health	and	social	care	that	such	phenomena	are	widely	
understood,	and	that	appropriate	service	developments	
are	identified,	funded	and	implemented.
Falling hospital bed numbers
The	number	of	hospital	beds	available	for	the	treatment	
of	inpatients	has	dropped	dramatically	since	the	start	of	
the	1950s.	At	that	time	there	were	roughly	11	beds	per	
1000	population	across	 the	UK	as	a	whole.	Today	 the	
equivalent	 figure	 is	 about	 3	 per	 1000,	 and	within	 that	
total	 there	 are	 approaching	 twice	 the	 number	 of	 beds	
per	capita	available	in	Scotland	as	there	are	in	England	
(Hawe	and	Cockcoft,	2013).	Even	since	the	late	1970s	
average	acute	bed	availability	per	1000	total	population	
has	 fallen	by	over	40	per	cent	 in	England.	The	decline	
in	 mental	 illness	 and	 learning	 difficulty	 inpatient	 beds	
available	 has	 been	 about	 twice	 that	 figure,	 and	 is	
projected	to	fall	further	in	the	coming	decade.
Such	 changes	 have	 been	 offset	 by	 reduced	 lengths	
of	stay	and	greater	use	of	day	surgery	 (Figure	7),	along	
with	 improved	 community	 (including	 nursing	 home	 and	
residential)	care.	Care	home	beds	are	a	critically	important	
resource,	 albeit	 their	 total	 number	 has	 also	 fallen	 since	
the	 1990s	 (Laing,	 2015).5	 In	 general	 the	 population	 is	
better	housed	and	more	able	to	cope	with	the	challenges	
of	recovery	or	living	with	mental	or	physical	disabilities	at	
home	than	was	so	when	the	NHS	came	into	being.
Even	 so,	 it	 is	 salient	 to	 note	 that	 the	NHS	 in	 England	
has	only	about	a	third	of	the	acute	hospital	beds	than	is	
the	case	in,	for	example,	modern	Germany,	and	that	in	
some	areas	shortages	of	social	service	and	community	
nursing	 resources	 are	 significantly	 delaying	 hospital	
discharges.	Recent	data	indicate	that	such	effects	lead	
to	the	loss	of	in	excess	of	a	million	hospital	‘bed	days’	a	
year	in	England	alone.	Failures	to	further	develop	primary	
care	as	defined	in	this	report	would	in	future	exacerbate	
problems	of	this	type.
5	 There	are	currently	around	400,000	public	and	private	residential	
and	nursing	home	beds	in	the	UK
Figure 7: Average length of hospital stays, 
England, 1998-2014, and day surgery numbers 
Source:	HSCIC,	2015b
Figure 6: UK resident population and 
projections by age group, 1951-2051
Projected	national	data
Note: in 1951 there were 200,000 British citizens aged 85 and over, 
compared to  about 1.5 million today. By 2051 this total will have risen  
to over 4 million. However,  in part because of immigration patterns the 
UK will by the 2030s have become one of the least aged countries in 
the EU, and in social and economic terms is likely to be significantly 
less affected by population ageing than countries such as China  
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Larger GP practices
At	the	start	of	the	1950s	there	were	some	22,000	GPs	
working	in	the	UK	NHS,	outnumbering	the	then	15,000	
hospital	 doctors	 by	 a	 third	 or	 more.	 Many	 practiced	
alone,	and	home	visiting	was	common	place.
Today	there	are	about	40,000	GPs	in	the	UK	as	a	whole,	
over	 three	 quarters	 of	whom	work	 in	 England.	 This	 is	
less	than	half	the	equivalent	number	of	hospital	doctors	
presently	employed.	Less	than	10	per	cent	of	GPs	now	
work	on	a	single	practitioner	basis,	and	home	visiting	by	
patients’	own	GPs	 is	 relatively	uncommon.	The	modal	
practice	size	has	risen	to	between	five	and	nine	medical	
members.	 In	 England	 practices	 rather	 than	 individual	
GPs	are	now	contracted	to	the	NHS	via	NHS	England,	
and	they	have	in	total	some	90,000	non-medical	full	time	
equivalent	(FTE)	staff	members.
Seventy	 per	 cent	 of	 the	 individuals	 employed	 as	 non-
medical	practice	staff	undertake	administrative	and	clerical	
work.	The	number	of	nurses	working	in	general	practices	
remains	relatively	modest	–	there	are	about	15,000	FTE	
practice	nurses	in	England,	which	translates	to	a	little	under	
25,000	 individuals.	 In	 recent	 years	 the	 ratio	 of	 practice	
nurses	to	GPs	has	remained	stable.	About	a	 third	of	all	
general	practice	consultations	are	undertaken	by	practice	
nurses	(Hawe,	2009).	They	are	now	responsible	for	over	
100	 million	 patient	 contacts	 a	 year	 out	 of	 the	 General	
Practice	total	of	approaching	350	million	consultations	a	
year	(Figures	8a	and	8b).	For	comparison	about	1.6	million	
people	a	day	use	community	pharmacies,	although	 the	
annual	number	of	health	related	consultations	undertaken	
in	pharmacies	has	been	estimated	 to	be	closer	 to	450	
million	(NHS	England,	2013).
From	 a	 demographic	 perspective,	 the	 proportion	 of	
female	 GPs	 has	 risen	 during	 the	 lifetime	 of	 the	 NHS.	
So	 too	 has	 the	 proportion	 of	 the	 GP	 workforce	 over	
50.	Over	 half	 of	 all	 family	 doctors	 are	 now	 in	 this	 age	
bracket.	 Presently	 available	 data	 suggest	 that	 many	
older	GPs	are	 (partly	 in	 response	 to	changing	pension	
fund	regulations,	and	new	limits	on	the	size	of	pension	
funds	that	enjoy	tax	benefits)	contemplating	retirement.	
This,	 coupled	 with	 uncertainties	 as	 to	 the	 proportion	
of	 younger	women	 doctors	who	will	 choose	 to	 return	
to	 practice	 after	 completing	 their	 families,	 has	 caused	
some	commentators	to	express	fears	that	GP	numbers	
will	soon	fall	dramatically.	It	has	been	claimed	that	around	
5	per	cent	of	surgeries	might	have	to	close	by	2020.
But	against	this	the	present	government	has	promised	to	
increase	the	GP	workforce	in	England	by	5,000	practitioners	
within	 five	 years	 (see	 next	 section).	 The	 likelihood	 of	 a	
significant	collapse	in	NHS	GP	care	provision	in	England	is	
limited.	However,	as	is	discussed	below,	there	will	almost	
certainly	be	an	increasing	need	to	employ	more	practice	
staff	such	as	nurses,	clinical	pharmacists	and	individuals	
with	non-clinical	backgrounds	who	have	been	trained	as	
physician	assistants	in	the	General	Practice	setting.	The	
development	of	community	pharmacies	in	ways	that	will	
relieve	GP	workloads	and	meet	NHS	user	expectations	for	
access	to	convenient,	safe	and	otherwise	valued	services	
could	also	prove	a	viable	way	forward,	if	adequate	action	
is	taken	to	secure	this	end.
Community pharmacy roles
There	 are	 presently	 approaching	 12,000	 community	
pharmacies	 in	 England,	 compared	 with	 8,000	 GP	
practices.	The	 latter	number	has	fallen	 in	recent	years,	
while	 the	 total	 for	 pharmacies	 has	 risen.	 There	 are	
around	 30,000	 community	 pharmacists	 employed	 in	
England,	which	represents	a	similar	number	to	that	 for	
GPs.	English	CPs	are	supported	by	over	100,000	other	
staff,	 ranging	 from	 registered	pharmacy	 technicians	 to	
counter	assistants	with	varying	levels	of	training.
Since	 the	 1950s	 there	 has	 not	 been	 an	 increase	 in	
the	 number	 of	 registered	 pharmacists	 working	 per	
community	 pharmacy	 comparable	 to	 that	 seen	 in	
Figure 8a. GP consultations per capita by age 
group, UK, 1975-2009 
Source:	OHE
Figure 8b. Total numbers of GP consultations 
by age group, UK, 1975-2009 
Source:	OHE
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relation	 to	 the	number	of	 doctors	working	per	general	
practice.	Relatively	few	pharmacies	have	more	than	one	
registered	pharmacist	on	duty	at	any	one	time.	But	the	
ownership	 of	 community	 pharmacies	 in	 England	 has	
become	more	corporate.	Outside	London,	over	60	per	
cent	 of	 all	 community	 pharmacies	 are	 now	 grouped	
in	 chains	 of	 five	 or	more	 (Figure	 9).	 At	 the	 same	 time	
the	annual	number	of	prescription	 items	dispensed	by	
community	pharmacies	in	England	alone	is	now	over	a	
billion.	This	compares	with	about	200	million	in	1950	and	
500	million	at	the	beginning	of	this	century.
A	number	of	factors	have	accounted	for	this	rise.	They	
range	 from	 an	 extended	 use	 of	 medicines	 to	 control	
vascular	disease	risks	through	to	the	increased	number	
of	older	people	living	in	the	community.	About	60	per	cent	
of	all	community	issued	prescriptions	are	now	dispensed	
for	people	aged	60	and	over,	which	 in	England	means	
that	the	average	individual	of	that	age	receives	well	over	
50	NHS	prescription	items	a	year.	The	equivalent	figure	
for	the	population	aged	under	60	years	is	approaching	9	
items	per	person	per	year.
It	might	be	argued	that	the	increased	workload	associated	
with	the	recent	growth	in	dispensed	item	numbers	(which	
over	 the	 last	decade	has	been	 linked	to	a	30	per	cent	
decline	 in	average	net	 ingredient	cost	per	prescription)	
will	 fully	occupy	most	community	pharmacists.	Yet	 the	
introduction	 of	 new	 dispensing	 technologies	 coupled	
with	 strategies	 ranging	 from	 the	more	 effective	 use	 of	
pharmacy	technicians	to	–	in	appropriate	circumstances	
–	increased	prescription	durations6	could	in	future	liberate	
pharmacist	time.	This	reality,	coupled	with	the	fact	that	
6	 There	is	evidence	that	it	is	not	always	in	patient	or	public	interests	
to	confine	supply	quantities	to	28	days	or	less	as	opposed	to,	say,	
three	month	periods.
at	present	pharmacy	 is	 the	only	health	profession	with	
a	surplus	of	UK	educated	graduates,	provides	evidence	
that	 there	 is	 a	 genuine	 opportunity	 for	 extending	 the	
clinical	 role	 of	 NHS	 community	 pharmacists,	 provided	
service	 users	 find	 this	 an	 attractive	 option	 and	 that	
pharmacist	and	other	stakeholders	have	the	necessary	
motivation	to	extend	their	clinical	care	inputs.
Community nursing
The	umbrella	 term	community	 nursing	 covers	 services	
provided	 by	 personnel	 ranging	 from	 district	 nurses	
to	 community	 matrons	 and	 health	 visitors.	 NHS	
community	 services	 also	 employ	 care	 assistants,	 as	
well	as	professionals	like	physiotherapists.	In	total,	even	
including	 nurses	 employed	by	Mental	Health	 Trusts	 to	
deliver	 community	 services,	 only	 about	 a	 fifth	 of	 the	
overall	 NHS	 nursing	 workforce	 is	 located	 outside	 the	
hospital	 sector.	 The	 available	 data	 indicate	 that	 since	
the	beginning	of	 this	century	 there	has	been	a	50	per	
cent	decline	 in	 the	number	of	 individuals	employed	as	
district	 nurses	 in	 England,	 leaving	 them	 at	 a	 ‘critically	
endangered’	level	(HSCIC,	2014).
Increases	in	the	number	of	other	staff	have	to	a	degree	
mitigated	this	trend.	Even	so,	the	Royal	College	of	Nursing	
(2012)	has	expressed	alarm	about	a	dilution	and	loss	of	
skills	in	the	community	nursing	workforce	in	a	period	in	
which	there	is	increasing	need	for	high	quality	community	
care.	There	is	evidence	that	in	some	areas	the	work	of	
community	 nursing	 teams	 has	 become	 dominated	 by	
inflexible,	 narrowly	 task	 oriented,	 approaches	 centred	
on	 relatively	 unskilled	 activities	 (Gill	 and	 Taylor,	 2011).	
Despite	recent	attempts	to	develop	more	integrated	care	
and	 initiatives	 such	as	 the	 establishment	 of	 the	Better	
Care	Fund,7	there	are	doubts	about	the	quality	of	social	
services	and	community	nursing	service	collaboration	in	
many	localities.
There	are	 likewise	concerns	about	the	‘dissociation’	of	
GP	and	broadly	defined	community	nursing	care.	In	less	
pro-active	 practices	 and	 localities	 there	 are	 problems	
relating	to	the	timely	delivery	of	good	quality	community	
services	to	people	living	with	conditions	that	put	them	at	
high	risk	of	emergency	hospital	admissions,	or	becoming	
prematurely	dependent	on	residential	care.
The	 historical	 origins	 and	 social	 status	 of	 nursing	 and	
allied	care	provision	in	this	country	are	quite	distinct	from	
those	of	medicine	and	pharmacy.	It	can	be	argued	that	
since	 the	 1974	NHS	 re-organisation	which	 transferred	
the	 provision	 of	 functions	 such	 as	 district	 nursing	
and	 health	 visiting	 away	 from	 Local	 Authority	 control,	
this	 area	 has	 lacked	 the	 supportive	 leadership	 and	
7	 This	as	from	April	2015	has	made	approaching	£4	billion	of	what	
is	in	large	part	funding	transferred	from	the	NHS	available	for	
Local	Authorities	and	CCGs	to	jointly	spend	on	social	and	allied	
community	services.
Figure 9: Number of community pharmacies 
owned by independent and multiple 
contractors* on a PCT pharmaceutical list, 
England 2006-2013
Source:	HSCIC,	2014b
* A multiple pharmacy is defined as one consisting of 6 or more 
pharmacies. Contractors with 5 pharmacies or less are regarded as 
independent.
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institutional	 sponsorship	 needed	 to	 protect	 public	 and	
patient	interests	in	its	ongoing	development.
Individuals	 interviewed	 during	 the	 development	 of	
this	 analysis	 highlighted	 funding	 and	 financial	 reward	
issues,	and	the	negative	impacts	that	creating	separate	
community	 matron	 posts	 may	 have	 had	 in	 terms	
of	 depriving	 district	 nursing	 teams	 of	 appropriate	
professional	 leadership.	 A	 core	 reason	 why	 it	 has	
been	 difficult	 to	 retain	 professional	 staff	 in	 community	
nursing	services	is	that	many	have	not	been	offered	an	
environment	 in	 which	 they	 feel	 it	 is	 attractive	 to	 work	
and	 possible	 to	 deliver	 high	 quality	 professional	 care.	
At	the	same	time	access	to	Local	Authority	social	care	
has	 decreased.	 Some	 commentators	 believe	 that	 the	
LA	commissioning	approaches	used	have	on	occasions	
‘auctioned	 down’	 the	 quality	 of	 social	 and	 community	
nursing	services	to	unacceptably	poor	levels.
The	problems	facing	NHS	community	service	providers	
have	now	in	part	been	acknowledged	by	agencies	such	
as	NHS	England.	It	recently	commissioned	the	Queen’s	
Nursing	 Institute	 to	develop	a	 resource	 to	help	ensure	
that	 localities	 have	 sufficient	 numbers	 of	 community	
nurses	 in	place.	 There	 is	 a	 commitment	 to	 training	 an	
additional	10,000	‘frontline’	community	nursing	staff	by	
2020,	 and	 the	 Primary	 Care	 Workforce	 Commission	
(2015)	 concluded	 that	 all	 localities	 should	 as	 a	matter	
of	priority	seek	to	have	an	adequate	24	hour	community	
nursing	service	in	place.
Such	 developments	 are	 encouraging.	But	 they	 should	
not	 conceal	 the	 systemic	 failure	 of	 the	 NHS	 in	 recent	
decades	 to	 develop	 community	 nursing	 and	 allied	
services	that	are	better	suited	to	meeting	the	needs	of	
a	 ‘post-transitional’	population.	The	approach	adopted	
in	 England	 may	 be	 seen	 as	 comparing	 poorly	 with	
examples	such	as	that	set	by,	for	instance,	the	Buurtzorg	
community	 care	programme	 in	 the	Netherlands	 (RCN,	
2015).
This	last	initiative	offers	an	illustration	of	‘self-managed’	
organisation.	Although	 its	 viability	 in	 the	more	 unequal	
and	 class	 divided	 British	 cultural	 environment	 has	 not	
been	 demonstrated,	 the	 Buurtzorg	 model	 (along	 with	
related	Swedish	strategies)	provides	a	setting	 in	which	
person-centred	 care	 can	 be	 delivered	 in	 ways	 which	
enable	nursing	and	other	non-medical	staff	a	high	level	
of	self-realisation	and	professional	reward.	It	is	therefore	
an	 important	 experiment	 for	 practitioners	 interested	 in	
realising	 the	promise	of	concepts	such	as	 the	NAPC’s	
‘Primary	Care	Home’	 to	explore.	 It	 is	possible	 that	 the	
thinking	 it	 embodies	 could	 be	 applied	 in	 ways	 which	
will	in	future	allow	better	collaborative	working	between	
GPs,	pharmacists,	community	nurses	and	other	primary	
health	 care	 colleagues	 in	 order	 to	 generate	 increased	
service	user	satisfaction	and	enhanced	care	outcomes.
Current Opportunities
The	 extent	 to	 which	 NHS	 primary	 care	 can	 currently	
be	said	 to	be	well	managed	 in	England	 is	debateable.	
The	 decades	 between	 the	 end	 of	 the	 1940s	 and	 the	
present	day	saw	what	might	be	termed	a	‘slow-motion	
managerial	 revolution’	 in	 the	 organisation	 of	 hospital	
care,	not	only	in	the	UK	but	also	in	much	of	Europe	and	
in	 the	 United	 States.	 Yet	 in	 the	 case	 of	 primary	 care,	
‘post	Griffiths’	general	management	has	not	in	the	main	
been	 developed,	 and	 where	 it	 has	 been	 instituted	 its	
achievements	have	been	of	questionable	desirability.
The	 recent	 establishment	 of	 Clinical	 Commissioning	
Groups,	coupled	with	the	formation	of	the	local	General	
Practice	Federations	 that	have	been	advocated	by	 the	
Royal	College	of	General	Practitioners	for	approaching	a	
decade	(Lakhani	et	al,	2007),	offers	improvements.	But	
despite	 recent	 steps	 like	extending	 the	part	played	by	
CCGs	in	the	development	of	primary	care,	this	hope	is	
accompanied	by	continuing	uncertainties.	Although	the	
post	 GP	 Fund-holding	 ‘commissioning	 experiment’	 in	
the	NHS	may	have	been	well	 intentioned,	many	of	 the	
professional	 and	 other	 leaders	 interviewed	 during	 the	
preparation	of	this	report	said	that	it	has	not	been	able	to	
adequately	facilitate	the	establishment	and	coordinated	
local	delivery	of	services	needed	by	communities	in	the	
late	stages	of	demographic,	epidemiological	and	social	
transition.	 In	 areas	 like	 Community	 Pharmacy	 positive	
change	has	also	–	although	cumulative	–	been	relatively	
slow,	while	 the	provision	of	skilled	district	nursing	care	
has	until	recently	at	least	been	in	decline.
As	 previously	 recorded,	 in	 the	 1960s	 the	 American	
sociologist	Eliot	Freidson	articulated	concerns	relating	to	
the	dominance	of	 the	medical	profession	 in	 the	health	
sphere,	 and	 what	 he	 judged	 to	 be	 a	 self-interested	
emphasis	 on	 ‘clinical	 freedom’	 as	 opposed	 to	 the	
appropriate	 provision	 of	 public	 and	 patient	 interest	
focused	care.	Yet	towards	the	end	of	his	career	Freidson	
had	 become	 worried	 about	 the	 unwanted	 impacts	 of	
health	 sector	 managerialism	 and	 regulatory	 systems	
that	 he	 increasingly	 saw	 as	 heralding	 destructive	
bureaucratisation.	 He	 feared	 that	 such	 trends	 were	
leading	 to	 controls	 that	 threaten	 patient	 interests	 by	
promoting	undue	rigidity	and	undermining	the	quality	of	
discretionary	 decision	 making	 in	 day-to-day	 treatment	
and	care.	Eliot	Freidson	in	effect	argued	that	professional	
values	are	needed	as	a	counter	balance	to	protect	service	
quality	 against	 inadequately	 informed	 managerialism	
and/or	political	interventionism	(Freidson,	2001).
The	NHS	today	differs	considerably	from	the	health	care	
system	 that	 existed	 in	 late	 twentieth	 century	 America.	
However,	 if	 in	 future	 NHS	 primary	 care	 is	 to	 be	 able	
to	 help	meet	 public	 expectations	 for	 both	 the	 efficient	
and	 effective	 use	 of	 hospital	 resources	 as	well	 as	 the	
provision	 of	 high	 standard	 community	 services,	 there	
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will	be	a	continuing	requirement	 to	complement	skilled	
managerial	direction	with	‘modern’	professionalism	and	
enhanced	responsiveness	to	the	preferences	of	service	
users	at	all	stages	of	their	lives.
During	 the	 prelude	 to	 the	 May	 2015	 general	 election	
NHS	 England’s	 Five Year Forward View highlighted	 a	
number	of	ways	in	which	primary	care	and	allied	service	
improvements	 might	 help	 generate	 the	 gains	 needed	
for	the	health	service	to	stay	within	budget	and	perform	
well	 in	 the	 period	 to	 2020.	 The	 advances	 suggested	
ranged	from	the	creation	of	urgent	care	networks	to	help	
manage	demand	for	emergency	treatments	through	to	
the	 (re)establishment	of	 ‘viable’	 local	hospitals	and	 the	
formation	of	Multispecialty	Community	Providers	(MCPs)	
and/or	 integrated	 Primary	 and	 Acute	 Care	 Systems	
(PACS).
These	 and	 other	 what	 are	 now	 termed	 ‘Vanguard’	
initiatives	 link	 back	 to	 earlier	 experimental	 schemes	
trialled	in	England,	including	the	sixteen	Integrated	Care	
Pilots	 (ICPs)	established	 in	 the	wake	of	 the	2008	NHS 
Next Stage Review.	MCPs	can	to	a	degree	be	compared	
to	 the	 polyclinic	 concept	 previously	 advocated	 by	
commentators	such	as	Lord	Darzi.	They	could	also	be	
developed	 in	ways	 that	 reflect	 the	 recent	 formation	 of	
Accountable	 Care	 Organisations	 in	 the	 United	 States.	
ACOs	 are	 groups	 of	 service	 providers	 that	 typically	
include	 primary	 care	 practitioners,	 nursing	 homes	 and	
hospitals,	 and	 that	 take	 responsibility	 for	 meeting	 all	
the	relevant	needs	of	a	given	population	for	a	specified	
period	of	 time	and	within	a	defined	budget	 (Shortell	et	
al,	2014).
There	are	a	variety	of	ways	in	which	NHS	primary	care	
could	develop	over	the	coming	decade	(Rosen,	2015).	
Of	 these	 it	 currently	 appears	 that	 defined	 budget	
initiatives	designed	to	meet	registered	population	needs	
over	specific	time	periods	are	the	most	promising.	There	
can	be	no	guarantee	that	forming	ACO	type	systems	will	
enable	the	NHS	to	overcome	the	challenges	now	facing	
it	 in	England	and	other	parts	of	 the	UK.	However,	 the	
National	Association	for	Primary	Care	(2015)	has	argued	
that	‘Primary	Care	Home’	based	models	that	reflect	the	
ACO	approach	deserve	close	attention.
Such	 organisations	 might	 in	 future	 be	 formed	 by	
building	on	 the	emergence	of	GP	Federations,	and	be	
designed	to	serve	populations	of	30-50,000	or	perhaps	
more	people.8	They	could	offer	benefits	similar	to	those	
attributed	to	the	‘multi-funds’	that	in	the	UK	formed	in	the	
later	stages	of	GP	Fund-holding.	Establishing	MCPs	in	a	
manner	 consistent	with	 the	NAPC’s	 recommendations	
does	not	 require	structural	mergers	which	dissolve	 the	
unique	 identities	 of	 smaller	 participant	 organisations.	
8	 Given	the	variability	of	local	community	care	requirements	and	
differing	service	development	opportunities	between	localities,	
attempting	to	impose	unduly	rigid	service	development	
specifications	would	risk	being	counter-productive.
Apart	from	the	motivational	advantages	this	might	bring,	
it	 could	 also	 permit	 the	 ongoing	 flexibility	 needed	 for	
new	configurations	to	form	with	a	minimum	of	disruptive	
impact	on	service	provisions,	as	and	when	this	would	be	
desirable.
The	 formation	 of	 Primary	 and	 Acute	 Care	 Systems	
(PACS)	also	relates	to	the	ACO	model,	the	establishment	
of	which	 in	America	was	stimulated	by	the	passage	of	
President	 Obama’s	 2010	 Affordable	 Healthcare	 Act.	
However,	PACS	are	arguably	more	likely	to	involve	formal	
mergers	of	hospital	and	primary	care	services.	Some	of	
those	 interviewed	during	 the	preparation	of	 this	 report	
suggested	that	this	would	be	a	robust	and	sustainable	
way	 forward,	 given	 the	 organisational	 strength	 and	
durability	of	 large	hospitals.	Others	argued	against	 this	
option,	in	part	because	of	fears	that	‘hospital	take-overs’	
could	damage	primary	care	and	distort	overall	patterns	
of	 service	 use.9	 They	 expressed	 the	 view	 that	 public	
interests	will	best	be	served	by	maintaining	a	clear	focus	
on	the	distinct	principles	for	excellence	 in	primary	care	
delivery	 established	 by	 researchers	 such	 as	 Starfield,	
and	 building	 logically	 on	 the	 discrete	 strengths	 of	 this	
country’s	established	primary	care	system.
The	 NHS	 structure	 and	 ‘single	 payer’	 funding	
system	 has	 some	 advantages	 as	 compared	with	 the	
alternative	 arrangements	 typically	 in	 place	 in	 other	
developed	 countries	 (Davis	 et	 al,	 2014).	 There	 is	 no	
reason	 to	 doubt	 that	 it	 could,	 given	 sufficient	 will,	
be	 further	 strengthened	 without	 counter-productive	
reorganisations.	 The	 importance	 of	 the	 National	
Association	for	Primary	Care’s	recent	‘7	point	plan’	and	
its	work	on	developing	the	Primary	Care	Home	concept	
of	a	practice	population	based	approach	to	effectively	
coordinating	personalised	health	and	social	 care	 is	 in	
part	 linked	 to	 the	 fact	 that	 it	 reflects	 a	 commitment	
to	 patient	 care	 centred	 values,	 coupled	with	 the	 use	
of	 appropriately	 designed	 performance	 and	 outcome	
metrics.	 Some	 important	 elements	 of	 the	 NAPC’s	
proposals	are	highlighted	in	Box	4.
Forming	 larger	 organisations	 is	 sometimes	 seen	 as	
a	means	of	 integrating	 complex	 activities.	But	 there	 is	
no	 evidence	 that	 simply	 bringing	 different	 health	 and	
social	 services	 together	 under	 a	 single	 management	
‘umbrella’	 would	 (as	 with	 the	 co-location	 of	 GPs	 and	
specialist	 doctors	 in	 shared	 premises)	 in	 itself	 create	
the	 relationships,	 values,	 commitment	 and	 expertise	
needed	 to	 sustain	 long	 term	 solutions	 to	 the	 multi-
faceted	 problems	 of	 optimising	 health	 and	 social	 care	
coordination.
9	 In	circumstances	where	hospitals	are	not	competing	for	market	
share	against	rival	providers	such	risks	may	be	significantly	
reduced.	Even	so,	the	view	taken	here	is	that	a	primary	rather	
than	secondary	care	led	approach	is	likely	to	enjoy	significant	
advantages	from	a	public	interest	perspective.
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The	history	of	community	nursing	after	1974	calls	 into	
serious	 doubt	 the	 wisdom	 of	 transferring	 the	 control	
of	 community	 service	 funding	 to	 bodies	 that	 have	 a	
dominant	 interest	 in	 institutional	 care	 provision.	 The	
fact	that	countries	like	Sweden	have	maintained	a	clear	
separation	 between	 health	 and	 social	 care	 in	 order	 to	
protect	 funding	 levels	 and	 maintain	 discrete	 service	
objectives	can	also	be	taken	to	be	indicative	of	the	need	
for	 caution	 with	 regard	 to	 adopting	 care	 integration	
strategies	 based	 on	 the	 imposition	 of	 organisational	
and	budgetary	unity,	as	distinct	from	preserving	‘natural’	
plurality	while	incentivising	functional	collaboration.
The	 next	main	 section	 of	 this	 report	 further	 discusses	
how	barriers	relating	to	the	provision	of	better	organised,	
individually	 responsive	yet	efficient	at	scale,	health	and	
social	care	might	best	be	overcome.	But	before	that	two	
areas	central	to	the	immediate	future	of	the	NHS	primary	
care	are	further	considered.	The	first	relates	to	how	the	
parts	 played	 by	 non-medical	 staff	 working	 in	 General	
Practice	 should	 be	 extended.	 The	 second	 further	
addresses	 how	 independently	 located	 community	
pharmacies	and	the	people	employed	in	them	will	best	
be	able	to	contribute	to	twenty	first	century	primary	care,	
alongside	other	service	providers.
The	fact	that	there	are	now	new	opportunities	for	clinical	
pharmacists	 to	 work	 in	 General	 Practice	 settings	 is	 a	
welcome	development.	But	 this	 should	not	undermine	
awareness	 of	 the	 continuing	 need	 for	 community	
pharmacies	to	supply	medicines	and	allied	products	 in	
convenient	and	cost-effective	ways,	or	of	opportunities	
for	 them	–	as	and	when	service	users	elect	 to	access	
pharmacies	 for	 health	 care	 delivery	 –	 to	 extend	 their	
contributions	to	facilitating	self-care	and	providing	direct	
access	to	pharmaceutical	and	allied	treatments	in	ways	
consistent	 with	 the	 cost-effective	 attainment	 of	 good	
quality	care	standards.
General Practice teams
When	 individuals	 are	 facing	 serious	 health	 problems	
many	 wish	 to	 be	 guided	 by	 GPs	 who	 they	 not	 only	
know	to	be	qualified	professionals	but	are	 familiar	with	
as	people	who	are	a	part	of	the	social	network/human	
capital	that	they	and	their	local	communities	‘own’,	and	
are	 hence	 highly	 trusted.	 Arguably,	 the	 fundamental	
test	 for	 General	 Practice	 in	 the	 period	 to	 2050	 is	 to	
retain	 its	 heritage	of	 being	 a	 local	 resource	 for	 patient	
populations	 while	 also	 being	 a	 major	 influence	 on	
clinical	commissioning.	 Ideally,	 it	needs	to	be	 ‘small’	 in	
personal	 relationship	 terms,	 yet	 ‘large’	 in	 the	 sense	of	
being	able	to	act	as	an	important	system-level	NHS	care	
commissioner	and	provider.
The	recently	announced	‘New	Deal	for	General	Practice’	
–	see	Box	5	–	recognises	the	centrality	of	GP	care	in	the	
NHS,	and	promises	to	increase	GP	numbers	in	England	
by	5,000	by	2020.	 It	also	offers	to	 increase	the	rest	of	
the	 General	 Practice	 workforce	 by	 a	 similar	 number,	
including	 a	 commitment	 to	 making	 1,000	 Physician	
Associates	available	 in	general	practices	by	the	end	of	
the	current	decade.
Box 4. Improving Primary Care
The	 National  Association	 of	 Primary	 Care’s	 7	 Point	
Plan (which	was	first	published	in	2014)	can	be	regarded	
as	 an	 attempt	 to	 apply	 evidence	 based	 principles	 of	
quality	 management	 to	 the	 delivery	 of	 person	 and	
patient	centred	population-wide	health	and	social	care.	
Its	key	priorities	relate	to:
•	defining	 the	 value	 of	 care	 around	 outcomes	 that	
matter	most	to	patients/service	users;
•	supporting	new	models	of	primary	care	provision	that	
should	 help	 to	 ensure	 that	 service	 users’	 personal	
requirements	are	met	effectively	and	efficiently;
•	aligning	 incentives	 and	 contractual	 models	 that	
support	 improvements	 in	 local	 population	 health	
outcomes;
•	developing	 a	 workforce	 that	 is	 responsive	 to	 the	
needs	 of	 the	 populations	 being	 served,	 rather	 than	
focused	on	meeting	those	of	the	professional	groups	
within	it;
•	supporting	‘real	time’	innovation	across	collaborative	
networks,	 in	part	 through	 the	 IT	based	use	of	well-
designed	 activity	 and	 performance	metrics	 in	 ways	
that	are	seen	as	important	by	all	those	taking	part;
•	purposeful,	not	just	positional,	leadership	representing	
the	breadth	of	primary	care;	and
•	working	 to	 influence	policies	 in	ways	 that	effectively	
support	the	realisation	of	the	ambitions	summarised	
above.
The	 thinking	 underpinning	 the	 NAPC’s	 Primary	 Care	
Home	concept	and	that	of	the	50	Vanguard	care	model	
implementation	 projects	 now	 (as	 of	December	 2015)	
being	supported	by	NHS	England	can	similarly	be	seen	
as	 seeking	 to	 apply	 the	 principles	 of	 service	 quality	
management	 to	 the	 task	 of	 continuously	 improving	
health	and	social	care.	Encouraging	progress	has	been	
reported.	However,	as	with	 the	multiple	pilot	projects	
that	 across	 the	world	 have	 repeatedly	 demonstrated	
the	 capacity	 of	 clinical	 pharmacy	 in	 both	 integrated	
and	independently	sited	community	settings	to	deliver	
good	 quality	 health	 care,	 core	 challenges	 relate	 to	
universalising	 good	 practices	 in	 ways	 that	 defend	
the	 local	 integrity	 of	 professional	 work	 and	 stimulate	
autonomous	improvement	practices.
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These	plans	in	part	stem	from	the	work	of	an	independent	
Primary	 Care	 Workforce	 Commission	 which	 formally	
published	 its	 report	 in	 the	 summer	 of	 2015	 (PCWC,	
2015).	The Future of Primary Care	noted	that	although	
the	 number	 of	 hospital	 consultants	 increased	 by	 48	
per	 cent	 in	 the	 decade	 2003-13,	 the	 number	 of	 GPs	
increased	by	only	14	per	cent.	Such	data	may	be	taken	
to	be	evidence	of	a	skewed	and	inadequately	managed	
pattern	of	workforce	investment	during	the	decade	or	so	
of	rapid	NHS	funding	growth	that	ended	shortly	after	the	
time	that	the	2008	global	financial	crisis	commenced.
During	the	first	10-15	years	of	this	century	primary	health	
and	 social	 care	 provision	 did	 not	 keep	 pace	 with	 the	
rapid	 expansion	 of	 complex	 specialist	 hospital	 activity,	
and	the	parallel	decline	in	hospital	bed	numbers	available	
in	England.	This	led	to	an	accumulation	of	risks.	Failures	
to	adequately	anticipate	and	forestall	this	situation	can	–	
notwithstanding	measures	such	as	the	introduction	of	a	
revised	national	contract	in	2004	that	rightly	or	wrongly	
removed	 GP	 responsibility	 for	 providing	 night	 and	
weekend	care	–	be	 taken	as	an	 illustration	of	not	only	
professional	 leadership	 limitations,	 but	 also	 significant	
weaknesses	 in	 NHS	 governance	 and	 direction	 at	 its	
higher	levels.
In	line	with	the	information	reported	earlier	in	this	review,	
the	Commission	also	observed	that	there	was	a	38	per	
cent	drop	in	the	number	of	community	nurses	in	the	ten	
years	2001-2011.	Only	 in	pharmacy	 are	 there	 enough	
new	 professionals	 being	 trained	 in	 the	UK	 to	meet	 or	
exceed	 anticipated	 future	 demands	 for	 health	 sector	
staff.	 In	 the	 institutional	 setting	 in	 particular,	 nursing	
care	in	Britain	has	in	recent	decades	been	substantially	
dependent	on	professionals	who	have	qualified	in	poorer	
countries.	Recently	announced	changes	 in	 the	 funding	
of	nursing	education	may	not	help	change	this	situation.
There	 have	 also	 been	 consistent	 shortfalls	 in	 the	
numbers	 of	 doctors	 trained	 in	 this	 country.	 This	 may	
in	 part	 have	 been	 related	 to	 attempts	 to	maintain	 the	
status	 and	 relative	 earnings	 of	medical	 staff	 trained	 in	
the	UK,	along	with	fears	that	British	graduates	will	if	there	
are	 not	 adequately	 attractive	 opportunities	 available	
domestically	 swiftly	 seek	 employment	 elsewhere	 in	
the	 English	 speaking	world.	 But	whatever	 the	 reason,	
many	of	the	NHS’s	current	financial	and	service	delivery	
Box 5. ‘New Deals’ for General Practice and Community Pharmacy?
In	 2014	 NHS	 England’s	 pre-election	 FYFV called	
for	 better	 funding	 and	 support	 for	 general	 medical	
practice,	in	order	to	further	improve	the	NHS’s	overall	
performance	through	enhanced	primary	and	secondary	
disease	prevention	and	better	population-wide	access	
to	 well-coordinated	 primary/community	 medical,	
nursing	 and	 pharmaceutical	 care.	 In	 June	 2015	 the	
Secretary	of	State	for	Health	offered	his	vision	of	a	‘new	
deal’	for	GPs	to	help	achieve	such	goals	in	England.
Drawing	in	part	on	the	work	of	the	‘Roland	Commission’	
–	 see	main	 text	 –	 the	 plan	 outlined	 by	 Jeremy	Hunt	
included	earmarking	£10	million	 for	general	practices	
in	 need	 of	 special	 support	 and	 the	 recruitment	 of	
5,000	 new	GPs	 and	 another	 5,000	 practice	 support	
staff	 (including	 practice	 nurses,	 district	 nurses,	
physicians’	 associates	 and	 practice	 based	 primary	
care	pharmacists)	by	the	end	of	the	current	Parliament.	
It	also	built	on	a	commitment	 to	provide	£550	million	
for	 the	modernisation	of	GP	surgeries	and	 improving	
community	 based	 care	 announced	 in	 March	 2015,	
and	 heralded	 contractual	 changes	 that	 should	 offer	
greater	 working	 freedoms	 for	 practices	 in	 return	
from	 the	 introduction	 of	 extended	 ’7	 day’	 NHS	 care	
arrangements.
Subsequently,	 it	 was	 also	 announced	 that	 everyone	
in	England	will	have	a	GP	who	is	recognised	as	being	
personally	accountable	 for	coordinating	 their	physical	
and	mental	health	care	needs.	The	Secretary	of	State	
in	addition	noted	the	importance	of	general	practice	in	
the	wider	public	health	context,	and	the	fact	that	about	
20	 percent	 of	 the	 average	 GP	 practice’s	 workload	
is	 associated	 with	 supporting	 people	 affected	 by	
problems	such	as	social	 isolation,	housing	difficulties,	
personal	 relationship	 issues	 and	 the	 consequences	
of	 unemployment.	 He	 emphasised	 the	 need	 for	
robust	 linkages	between	general	 practice	 and	 social,	
community	and	mental	health	care.
This	 package	 of	 initiatives	 has	 been	 generally	
welcomed,	 although	 warnings	 have	 been	 sounded	
with	regard	to	issues	such	as	the	extent	to	which	the	
financial	incentivisation	of	specific	professional	practice	
improvements	 could	 have	 perverse	 consequences	 in	
other	important	areas	of	work	that	do	not	receive	special	
funding.	From	the	perspective	of	this	report	it	may	also	
be	suggested	that	more	attention	might	usefully	be	paid	
to	the	establishment	of	a	parallel,	effectively	integrated,	
‘new	deal’	for	community	pharmacists	working	outside	
the	general	medical	practice	setting.
Recent	calls	by	the	Treasury	to	increase	the	use	of	online	
pharmacy	 and	 home	 delivery	 services	 (Cmnd	 9164,	
2015)	appear	to	be	supportive	of	drug	distribution	cost	
saving	strategies	that	might	 in	time	 lead	to	significant	
reductions	in	the	numbers	of	independent	and/or	chain	
pharmacies	 across	 the	 UK.	 However	 –	 as	 initiatives	
such	as	the	development	of	Healthy	Living	Pharmacies	
may	 be	 taken	 to	 indicate	 –	 it	 could	 well	 prove	
counter-productive	 to	 ignore	 the	 actual	 and	potential	
contributions	 of	 pharmacies	 to	 clinical	 care	 delivery	
and	wider	 public	 health	 improvement,	 especially	 if	 in	
future	 the	 ‘public	 health’/population	 level	 preventive	
use	 of	medicines	 outside	 the	 conventional	 sphere	 of	
disease	treatment	in	doctors’	surgeries	becomes	–	as	
is	discussed	in	Box	7	below	–	more	widely	accepted.
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problems	 can	 be	 linked	 to	 an	 inadequate	 supply	 of	
suitably	skilled	staff.
The	Primary	Care	Workforce	Commission	recommended	
that	 GPs	 should	 retain	 their	 central	 responsibility	 for	
primary	medical	care	quality	and	the	delivery	of	person	
centred	 support.	 It	 also	 argued	 that	 the	 balance	 of	
General	Practice	activities	should	over	time	move	more	
towards	 incorporating	population	based	 ‘public	health’	
approaches	 in	 relation	 to	 the	 management	 of	 health	
related	risks.	Greater	numbers	of	non-medical	practice	
staff	 could	 help	 to	 make	 the	 adoption	 of	 ‘community	
oriented	primary	care’	strategies	(see	Geiger,	1993)	and	
practices	possible.
For	example,	The Future of Primary Care	claimed	that	if	
medical	assistants	were	to	undertake	50	per	cent	of	the	
administrative	work	currently	done	by	GPs,	 this	would	
release	the	equivalent	of	1400	doctors	for	clinical	work	in	
England.	Physician	associates	(graduates	with	relatively	
brief	training	in	key	health	care	areas)	could	also	take	on	
more	primary	 care	 tasks,	 as	 too	 –	depending	on	 their	
availability	–	could	nurse	practitioners	and	pharmacists	
working	 in	 practice	 settings.	 Shortly	 before	 the	
publication	 of	 the	 Commission’s	 report,	 NHS	 England	
announced	pilot	funding	for	‘practice	pharmacy’	posts.
So	 far	 funds	 sufficient	 for	 the	 support	 of	 about	 400	
such	 appointments	 have	 been	 announced.	 Employing	
pharmacists	in	GP	surgeries	can	be	taken	as	recognition	
of	their	value,	and	might	help	provide	a	partial	solution	to	
limitations	in	the	number	of	doctors	seeking	careers	as	
GPs.	Yet	the	long	term	economic	sustainability	of	such	a	
way	forward	is	as	yet	uncertain.	There	will	be	significant	
costs	 to	 be	 met	 in	 successfully	 establishing	 a	 more	
team	 based	 model	 of	 primary	 medical	 care	 delivery.	
But	 its	 advantages	 should	 include	 allowing	 longer	 GP	
consultation	 times	 for	 patients	with	 relatively	 extensive	
needs.	Other	Commission	recommendations	related	to:
•	 encouraging	 greater	 use	 of	 emails	 and	 (security	
permitting)	web	based	communications	in	both	intra-
professional	and	practitioner/patient	interactions;
•	 creating	single	points	of	access	for	community	health	
and	social	care	needs	assessments;
•	 improving	 career	 structures	 for	 nurses	 and	 others	
working	in	primary	health	care;
•	 funding	24	hour	7	day	community	nursing	services	to	
facilitate	timely	hospital	discharges;
•	 ensuring	that	there	is	equitable	geographical	access	
to	good	quality	General	Practice;	and
•	 developing	 local	 Federations	 that	 involve	 both	 GPs	
and	community	pharmacists.
The	extent	to	which	such	aspirations	can	be	translated	
into	actual	service	improvements	will	in	large	part	depend	
on	 the	 financial	 and	 allied	 incentives	 influencing	 the	
behaviours	of	individuals	and	organisations.	Constructive	
change	 in	 General	 Practice	 and	 other	 primary	 care	
services	 will	 be	 possible	 if	 it	 is	 pursued	 in	 a	 realistic	
manner	and	development	 investment	 is	sustained	over	
sufficient	periods	of	time.
However,	 if	 the	 performance	 of	 NHS	 primary	 care	 in	
delivering	 not	 only	 continuing	 personal	 support	 for	
individuals	living	with	complex	needs	but	also	interventions	
for	people	who	 require	quick	and	easy	service	access	
is	 to	be	optimised,	 improving	practice	based	care	co-
ordination	is	not	the	only	goal.	Despite	some	outstanding	
examples	of	comprehensive	provision,	it	is	highly	unlikely	
that	 larger	General	Practices	will	be	able	 to	meet	both	
the	growing	need	for	continuing	medical	care	for	more	
seriously	ill	individuals	and	parallel	demands	for	the	rapid	
and	 convenient	 delivery	 of	 preventive	 and	 day-to-day	
self-care	support	and	‘maintenance’	services	for	children	
and	adults.	Additional	ways	of	offering	safe,	timely	and	
convenient	treatment,	support	and	advice	are	also	likely	
to	be	required.
Clinical pharmacy in the community
Before	 the	 establishment	 of	 the	 NHS,	 community	
pharmacists	 in	 Britain	 played	 an	 important	 part	 in	
providing	 health	 care	 as	 well	 as	 in	 dispensing	 the	
comparatively	 limited	 (often	 pharmacy	made)	 range	 of	
effective	medicines	 then	 available.	 But	 the	 creation	 of	
the	health	service	coincided	with	the	first	pharmaceutical	
revolution.	 This	 generated	 a	wave	 of	 drug	 innovations	
that	 started	 with	 the	 introduction	 of	 new,	 industrially	
manufactured	 and	 packaged,	 antibiotics	 like	 the	
penicillins	and	the	tetracyclines,	coupled	with	products	
like	 isoniazid	 for	 the	 treatment	 of	 tuberculosis.	 Such	
developments	were	 followed	 later	 in	 the	1950s	by	 the	
marketing	of	products	such	as	the	early	anti-depressants,	
diuretics	for	the	control	of	blood	pressure,	polio	vaccines	
and	the	first	oral	contraceptives.
Combined	with	NHS	funded	access	to	medically	prescribed	
items	 (prescription	 only	 medication	 was	 also	 a	 relatively	
novel	concept	at	that	time),	pharmaceutical	progress	greatly	
increased	the	Community	Pharmacy	dispensing	workload.	
Pharmacists	 became	 less	 engaged	 with	 treating	 health	
problems	directly,	and	more	narrowly	focused	on	medicine	
supply	(Taylor	and	Carter,	2002;	Anderson,	2007).
Today,	 General	 Practices	 are	 larger	 and	 more	 difficult	
to	access	than	in	the	past	and	are,	as	already	outlined,	
having	 to	 deal	with	 patient	 and	 population	 needs	 that	
differ	markedly	 from	 the	 infection	 related	 requirements	
that	 were	 more	 prevalent	 when	 the	 NHS	 was	 first	
established.	 At	 the	 same	 time	 new	 technologies	 and	
better	use	of	skilled	pharmacy	technicians	are	promising	
ways	of	freeing	pharmacists	from	at	least	some	aspects	
of	 the	 medicines	 supply	 and	 dispensing	 task,	 and	 of	
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improving	communication	and	 record	sharing	between	
all	NHS	service	providers	and	users.
In	 England,	 changes	 ranging	 from	 the	 introduction	 of	
more	GSL	and	P	(free	sale	and	pharmacy	only)	medicines	
to	 the	 funding	 of	 ‘minor’	 ailment	 treatment	 initiatives,	
smoking	cessation	services	and	other	 local	schemes	–	
alongside	the	national	funding	of	Medicine	Use	Reviews	
(MURs)	and,	more	recently,	the	New	Medicines	Service	
(NMS)	–	can	be	seen	as	preparing	community	pharmacy	
for	the	delivery	of	an	extended	primary	health	care	role.	
The	 same	 may	 be	 said	 of	 initiatives	 such	 as	 repeat	
dispensing	schemes,	the	establishment	of	‘Healthy	Living	
Pharmacies’,	and	the	different	but	related	approaches	to	
developing	community	pharmacy	being	 introduced	not	
only	in	UK	countries	like	Scotland	but	in	national	settings	
like	those	of	Australia,	Canada	and	the	US	(Box	6).
In	 recent	 decades	 there	 has	 been	 an	 increased	
understanding	 of	 issues	 such	 as	 how	 community	
pharmacy’s	 traditional	 ‘volume	supply’	based	business	
model	 and	 in	 the	 UK	 the	 matching	 structure	 of	 NHS	
pharmacy	contracts	has	tended	to	curb	the	profession’s	
ability	 to	 move	 from	 dispensing	 towards	 clinical	 care,	
and	 provide	 services	 that	 require	 time	 to	 be	 spent	 on	
establishing	 flexible	 dialogues	 with	 service	 users	 in	
order	 to	provide	effective	solutions	to	health	problems.	
Yet	 there	 is	 also	 growing	 evidence	 on	 the	 capacity	 of	
pharmacy	based	services	to	deliver	better	outcomes	in	
areas	such	as	the	support	of	people	with	conditions	like	
COPD,	asthma,	chronic	pain	or	diabetes.
Nationally	and	internationally,	research	findings	from	pilot	
schemes	 indicate	 that	 Community	 Pharmacists	 could	
play	 more	 important	 roles	 in	 areas	 ranging	 from	 the	
detection	of	mental	health	problems	to	the	management	
of	 long	 term	 physical	 conditions	 and	 the	 reduction	
of	 vascular	 disease	 risks	 like	 raised	 blood	 pressure	
in	 middle	 and	 later	 life	 (Box	 7).	 However,	 despite	 a	
plethora	of	examples	of	successful	small	scale	initiatives,	
pharmacists	 have	 across	 the	world	 faced	problems	 in	
establishing	‘scaled	up’	health	care	roles.	Finding	ways	
to	augment	and	over	time	replace	‘item	of	service’	based	
dispensing	 income	 streams	 with	 a	 sustainable	 health	
care	revenue	base	lies	at	the	heart	of	this	challenge.
The	 view	 taken	 here	 is	 that	 independently	 located	
pharmacies	and	pharmacists	could	and	should	in	future	
play	a	more	central	part	in	providing	easier	first	and	when	
appropriate	subsequent	access	to	clinical	care,	provided	
that	in	future	all	primary	care	interventions	are	–	with	due	
service	user	permission	–	entered	into	a	common	health	
Box 6. National and Global Pharmacy Developments
Throughout	 Western	 Europe	 and	 North	 America	
many	examples	are	available	of	community	pharmacy	
based	initiatives	that	promise	better	health	outcomes.	
Well	researched	illustrations	of	the	latter	exist	in	areas	
ranging	 from	 the	 prevention	 and	 treatment	 of	 type	 2	
diabetes	and	its	precursor	states	through	to	disorders	
such	as,	for	instance,	osteoporosis	(Taylor	et	al,	2015).	
In	countries	 like	Canada	 there	has	also	been	general	
progress	 towards	 pharmacist	 prescribing	 in	 not	 only	
emergency	situations	but	 in	 the	management	of	 long	
term	conditions.	The	best	known	instance	of	this	relates	
to	the	provisions	for	independent	pharmacist	treatment	
instituted	 in	 Alberta,	 although	 related	 advances	 have	
also	been	achieved	in	other	Provinces.
In	 the	 UK	 relevant	 pharmacy	 development	 examples	
include	the	introduction	of	NHS	funded	Medicines	Use	
Reviews	in	England	in	2005,	the	establishment	of	the	
Scottish	Chronic	Medication	Service	 in	2010	and	 the	
formation	 of	 the	 English	 New	 Medicines	 Service	 in	
2013.	 The	 latter	 seeks	 to	 support	 medicines	 taking	
in	the	especially	vulnerable	period	after	treatments	for	
long	term	use	have	first	been	prescribed.	 In	addition,	
local	 initiatives	 such	 as	 the	 Community	 Pharmacy	
Future	(CPF)	project	–	a	collaboration	between	Boots	
UK,	The	Co-operative	Pharmacy,	Lloyds	Pharmacy	and	
Rowlands	Pharmacy	 –	 have	 highlighted	 the	 potential	
value	of	extended	pharmaceutical	care.
The	results	of	the	CPF	indicated	that	some	£400	million	
a	year	could	accrue	to	the	NHS	in	England	from	work	
in	just	one	field,	that	of	the	early	detection	of	Chronic	
Obstructive	 Pulmonary	 Disease	 and	 the	 appropriate	
care	and	support	of	individuals	and	families	affected	by	
COPD.	Other	 examples	 of	 innovative	 pharmaceutical	
care	 provision	 range	 from	 the	 encouragement	 of	
‘pharmacy	 first’	 approaches	 to	 seeking	 care	 for	
common	 conditions	 in	 Yorkshire	 through	 to	 greater	
pharmacist	 involvement	 in	 clinical	 research	 and	 the	
treatment	of	skin	conditions	in	Cornwall	(Turner,	2015;	
Bearman,	2015).
As	 general	 medical	 practices	 grow	 larger	 and	 more	
complex,	 the	 NHS	 and	 pharmacists	 working	 in	 it	
will	 (along	 with	 other	 health	 professionals)	 have	
increasing	 opportunities	 for	 systematically	 extending	
the	clinical	and	allied	preventive	support	offered	to	the	
public	 in	 easily	 accessible	 premises,	 provided	 these	
can	 be	 satisfactorily	 linked	 via	 robust	 IT	 systems	 to	
GP	 practices	 and	 other	 primary	 care	 facilities.	 This	
approach,	which	may	to	a	degree	be	taken	to	mirror	the	
primary	and	secondary	health	centre	model	envisaged	
by	Lord	Dawson	almost	a	century	ago,	might	well	 in	
time	 generate	 major	 economies	 in	 ways	 genuinely	
consistent	 with	 better	 service	 quality	 and	 outcomes.	
However,	immediate	pressures	for	cost	savings	in	the	
narrower	field	of	drug	distribution	may	impair	the	‘reach’	
of	the	current	community	pharmacy	network	before	its	
new	utilities	can	emerge,	unless	 relatively	 rapid	steps	
are	 taken	 towards	 realising	 community	 pharmacy’s	
extended	promise.
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record.	The	establishment	of	 the	 latter	 in	 the	NHS	will	
open	the	way	to	independently	sited	pharmacy	services	
being	able	to	improve	access	to	a	variety	of	diagnostic	
and	therapeutic	services	without	the	integrity	of	medical	
and	wider	health	records	being	undermined.
This	is	not	to	deny	the	value	of	GPs	being	able	to	build	
up	continuing	relationships	with	patients	in	ways	which	
will	 help	 them	 to	 identify	 atypical	 states	 and	 serious	
illnesses	as	and	when	they	occur.	But	it	is	to	accept	that	
many	 interventions	–	 like,	 for	 instance,	 vaccinations	or	
prescribing	medicines	 for	 ‘first	contact’	 and	preventive	
purposes	 and	 for	 treating	 common	 (as	 distinct	 from	
minor)	 chronic	 illnesses	 –	 could	 often	 be	 conveniently	
delivered	in	pharmacies	as	well	as,	when	service	users	
prefer	it,	in	general	practices.
Not	 all	 health	 policy	 analysts	 accept	 the	 case	 for	
extending	 the	 clinical	 role	 of	 community	 pharmacists.	
They	argue	 instead	 that	 it	would	be	better	 for	 them	to	
focus	on	minimising	drug	supply	 costs	and	optimising	
the	 prescribing	 and	 use	 of	 medicines.	 For	 instance,	
Mossialos	 et	 al	 (2013)	 warned	 that	 (internationally)	
attempts	 to	 change	 the	 role	 of	 CPs	 could	 cause	
disruptive	 pressures	 elsewhere	 in	 primary	 health	 care	
economies.	 They	 suggested	 that	 there	 is	 to	 date	
inadequate	evidence	that	community	pharmacists	have	
the	competencies	needed	to	deliver	clinical	care	to	the	
standards	 achieved	by	 nurses	 and	doctors	 in	 hospital	
clinics	or	by	GPs	and	their	practice	team	members.
The	 HOMER	 trial	 of	 home	 based	 medication	 review	
(Holland	et	al,	2005)	is	a	source	of	evidence	sometimes	
quoted	 in	 support	 of	 such	 views.	 It	 found	 that	 home	
visits	 to	patients	by	pharmacists	undertaken	after	 they	
had	been	discharged	 from	hospital	care	 in	East	Anglia	
in	 order	 to	 help	 improve	 medicines	 taking	 had	 the	
paradoxical	 effect	 of	 increasing	 hospital	 re-admission	
rates,	without	enhancing	survival	 rates	or	quality	of	 life	
related	 outcomes.	 This	 research	 also	 generated	 data	
indicating	 that	 the	 didactic	 approach	 taken	 by	 the	
pharmacists	involved	in	this	project	undermined	patients’	
confidence	in	their	medicines	taking	abilities,	and	hence	
was	 likely	 to	 have	 impaired	 rather	 than	 improved	 their	
drug	usage	(Bienkowska-Gibbs	et	al,	2015).
However,	it	is	important	not	to	over-state	the	significance	
of	 such	 studies.	 With	 regard	 to	 the	 HOMER	 trial,	 for	
instance,	 the	 research	 conducted	 did	 not	 involve	
community	or	primary	care	pharmacists	with	established	
relationships	 with	 local	 GPs	 and	 the	 patients	 being	
treated	(Smith,	2015).	Individuals	working	in	primary	care	
situations	 with	 which	 they	 are	 not	 adequately	 familiar	
and	for	which	they	have	not	been	fully	trained	cannot	be	
expected	to	generate	the	same	outcomes	as	those	who	
have	established	robust	contextual	relationships	and	are	
better	aware	of	both	the	problems	to	be	avoided	and	the	
opportunities	to	be	taken.
With	 regard	 to	 the	 conclusions	 reached	 by	Mossialos	
and	his	colleagues,	they	may	not	apply	in	the	context	of	
Box 7. Reducing the Age Specific Incidence of Vascular Disease and Dementias through new 
models of Pharmaceutical Care
In	 December	 2015	 the	 President	 of	 the	 Academy	 of	
Medical	Sciences,	Professor	Sir	Robert	Lechler,	called	
for	more	attention	to	be	paid	to	the	opportunities	for	new	
and	established	medicines	to	be	used	as	instruments	
for	 prevention	 and	 public	 health	 improvement,	 as	
opposed	to	their	traditional	applications	as	curative	or	
symptom	 relieving	 agents	 (Brimelow,	 2015).	 To	 date	
the	most	widely	publicised	example	of	such	a	strategy	
relates	 to	 the	proposed	use	of	statins	 in	combination	
with	 low	 dose	 anti-hypertensives	 for	 the	 primary	
prevention/delay	of	events	such	as	strokes	and	heart	
attacks	(Wald,	2015).
Such	 thinking	 has	 to	 date	 proved	 controversial,	 not	
only	because	of	apparent	concerns	about	drug	safety	
and	 the	 relative	 desirability	 of	 promoting	 healthy	 life	
styles	 rather	 than	 medicines	 use,	 but	 also	 because	
of	 its	 potential	 impacts	 on	 GP	 practice	 workloads.	
It	 may	 be	 argued	 that	 if	 doctors	 spend	 too	 much	
time	 on	 preventive	 activities	 of	 any	 type,	 access	 to	
medical	 care	 in	 the	 event	 of	 frank	 disease	 could	 be	
undesirably	 reduced.	 Some	 commentators	 might	
also	 –	 even	 if	 immediate	 safety	 issues	were	 resolved	
beyond	reasonable	doubt	–	be	opposed	to	permitting	
alternative	 health	 care	 providers	 to	 facilitate	 public	
access	 to	 medicines	 such	 as	 combination	 products	
for	the	primary	prevention	of	vascular	disease.	This	 is	
because	 of	 the	wider	 impacts	 this	may	 have	 on	 the	
medical	control	of	access	to,	and	the	public’s	use	of,	
medicinal	drugs	as	a	whole.
Beyond	vascular	disease	prevention,	 there	are	already	
other	 areas	 in	 which	 non-conventionally	 supplied	
pharmaceutical	 interventions	are	having	or	could	have	
important	 ‘public	 health’	 impacts.	 They	 range	 from	
smoking	 cessation	 support	 and	 the	 control	 of	 dental	
caries	 to	 the	 prevention	 of	 HIV	 transmission	 and	 –	
potentially	at	least	–	the	occurrence	of	osteoporotic	spinal	
disorders	 and	 some	 cancers.	 As	 bio-pharmaceutical	
innovation	 continues	 and	 humanity’s	 knowledge	 of	
fundamental	 disease	 causes	 and	 developmental	
pathways	 expands,	 many	 additional	 opportunities	 for	
such	preventive	interventions	will	emerge.
In	the	coming	ten	to	twenty	years	this	is,	for	example,	
likely	 to	 be	 so	 in	 relation	 to	Alzheimer’s	Disease	 and	
other	 forms	 of	 dementia.	 Figure	 2	 (page	 3)	 of	 this	
report	suggests	that	in	future	community	pharmacists	
might	be	able	cost	effectively	to	play	an	extended	role	
in	helping	healthy	people	 to	choose	pharmaceutically	
based	preventive	care,	as	well	as	in	areas	like	enhancing	
access	to	genetic	and	other	risk	testing	and	promoting	
health	protective	lifestyles.
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nations	like	England	where	primary	care	faces	significant	
shortfalls	in	medical	staff	availability.	Throughout	the	UK	
significant	 effort	 has	 already	 been	 put	 into	 preparing	
for	 substantive	 extensions	 in	 the	 role	 of	 pharmacists.	
Qualitative	interviews	undertaken	to	inform	this	analysis	
suggested	a	degree	of	medical	as	well	as	public	support	
for	the	concept	of	providing	clinical	pharmaceutical	care	
in	not	only	hospital	clinics	and	GP	practices,	but	also	in	
the	independent	community	pharmacy	setting.
This	is	not	to	deny	the	need	for	appropriate	competency	
assessments	 and	 Community	 Pharmacy	 staffing	 and	
governance	standards,	or	that	on	occasions	pharmacists	
themselves	 may	 be	 reluctant	 to	 adapt	 their	 ways	 of	
working	 to	 meet	 new	 patterns	 of	 need	 and	 service	
affordability.	But	 if	 innovations	such	as	the	 introduction	
of	graduate	‘physician	assistants’	are	to	be	 introduced	
in	General	Practice	it	would	seem	perverse	to	reject	the	
further	extension	of	appropriately	structured	health	care	
delivery	 roles	 in	 regulated	pharmacy	settings.	Likewise	
if	 the	 further	development	of	nurse	practitioner	 roles	 in	
community	settings	is	to	be	welcomed,	the	same	might	
be	taken	to	apply	to	pharmaceutical	care	extensions	in	
not	only	general	practice	but	also	in	independently	sited	
pharmacies.
Innovation	cannot	normally	be	achieved	without	 taking	
managed	risks.	Waiting	for	definitive	evidence	of	safety	
and	effectiveness	to	emerge	before	adopting	new	service	
concepts	can	be	a	recipe	for	stasis.	The	transformative	
idea	of	the	NHS	itself	would	almost	certainly	have	been	
still	born,	had	not	the	national	 leaders	of	the	day	been	
determined	to	proceed	on	the	basis	of	 logic	and	good	
will	at	a	 time	when	 the	country	was	 recovering	 from	a	
period	of	extreme	danger	and	great	financial	loss.	Today,	
by	contrast,	British	society	is	more	secure	and	in	some	
respects	more	risk	averse	than	it	has	ever	been	before.	
However,	 if	 primary	 care	 in	 general	 and	 Community	
Pharmacy	in	particular	are	to	move	forward	in	ways	that	
offer	significant	improvements	for	service	users,	decisive	
policy	choices	are	ultimately	going	to	have	to	be	made.
Achieving Faster Access to 
Better Care
Figure	10	outlines	a	possible	future	model	for	NHS	primary/
community	health	and	social	care.	A	single	‘one	size	will	fit	
all’	approach	cannot	be	applied	in	every	urban	and	rural	
area	of	a	country	as	diverse	as	England	 is	 today.	There	
is	no	one	‘magic	bullet’	solution	capable	of	guaranteeing	
answers	to	all	the	care	cost	and	quality	challenges	facing	
the	 NHS.	 But	 it	 is	 realistic	 to	 seek	 a	 broad	 framework	
within	which	‘pro-active	General	Practice	and	Community	
Pharmacy’	could	more	effectively	work	with	care	providers	
such	as	community	nurses,	social	 service	professionals	
and	 specialist	 physicians	 to	 deliver	 better	 support	 to	
people	living	with	conditions	that,	without	good	care,	are	
likely	to	result	in	a	poor	quality	of	daily	life	punctuated	by	
recurrent	inpatient	admissions.
The	 unique	 success	 of	 general	 practice	 throughout	
the	UK	is	based	on	continuity	of	personal	care	delivery	
coupled	with	the	capacity	to	understand	and	meet	the	
needs	of	 registered	practice	populations.	Yet	 although	
GPs	play	a	vital	part	in	primary	care,	a	constructive	vision	
for	the	future	should	not	over-emphasise	their	centrality,	
or	 deny	 the	 importance	 of	 forming	 good	 relationships	
between	 all	 actors	 in	 the	 NHS	 (Colin-Thomé,	 2011).	
Well-coordinated	and	clinically	empowered	Community	
Pharmacy	services	could,	for	example,	contribute	more	
to	the	appropriate	management	of	long	term	conditions	
in	partnership	with,	or	as	an	integral	part	of,	bodies	such	
as	GP	Federations	and/or	organisations	such	as	MCPs.
To	 be	 cost	 effective,	 this	 will	 almost	 certainly	 require	
them	 to	 become	 an	 alternative	 direct	 source	 of	 some	
types	of	care	currently	offered	in	General	Practice,	rather	
than	merely	a	provider	of	services	aimed	at	augmenting	
work	 that	 continues	 to	 be	 done	 by	 GPs	 and	 their	
immediate	colleagues.	There	 is	good	reason	to	believe	
that	as	IT	based	links	and	diagnostic	and	other	support	
instruments	become	increasingly	available	in	pharmacy	
settings	and	in	places	like	residential	and	nursing	homes,	
pharmacists	will	 –	subject	 to	 regulatory	 restraints	–	be	
able	 to	 offer	 a	 progressively	 widening	 range	 of	 direct	
access	illness	and	preventive	services.
With	 regard	 to	 supplementary	 and	 independent	
pharmacist	prescribing,	a	degree	of	progress	has	been	
made	in	the	UK	over	the	course	of	the	last	decade.	But	
despite	the	importance	of	medicines	and	medicines	use	
expertise	 to	 the	 identity	 of	 pharmacy	 as	 a	 profession,	
it	 is	 arguable	 that	 more	 significant	 advances	 have	
Funding and strategic direction from NHS England and LATs
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to	 date	 been	 made	 in	 the	 field	 of	 nurse	 prescribing.	
Internationally,	 it	 could	 also	 be	 said	 that	 pharmacy	
prescribing	in	England	is	not	as	far	as	advanced	as	it	is	
settings	such	as,	for	instance,	Alberta	in	Canada.
The	extent	of	such	differences	should	not	be	exaggerated	
(see,	 for	 instance,	Makowsky	and	Guirguis,	2014).	But	
it	 may	 be	 concluded	 that	 for	 future	 ‘pharmacy	 first’10	
policies	to	be	effective	it	will	be	essential	for	community	
pharmacists	to	be	able	to	combine	extended	prescribing	
competencies	 with	 their	 dispensing	 management	 and	
supervisory	 capabilities.	Relaxations	 in	 regulations	 that	
presently	 prevent	 independent	 local	 NHS	 pharmacies	
from	 sharing	 the	 use	 of	 robotic	 dispensing	 machines	
is	one	example	of	 the	 type	of	 reform	 that	might	 foster	
future	service	improvements.
Important	 progress	 towards	 transforming	 primary	 care	
provision	 is	 already	 taking	 place	 in	 ‘Vanguard’	 sites	
and	 in	a	number	of	other	 localities	 (Shortt,	2015).	The	
efforts	 of	 agencies	 like	 the	 RCGP,	 the	 NAPC	 and	 the	
Royal	 Pharmaceutical	 Society	 are	 also	 of	 value.	 It	 is	
encouraging,	for	instance,	that	the	National	Association	
for	Primary	Care’s	 initial	Primary	Care	Home	proposals	
have	received	support	from	NHS	England.	Other	relevant	
initiatives	 range	 from	the	establishment	of	pooled	 local	
health	and	social	care	funding	systems	through	to	recent	
plans	 for	 a	 new	 voluntary	 General	 Practice	 contract.	
This	 could,	 in	 return	 for	 extended	 commitments	 to	
seven	 day	 service	 provision,	 offer	 a	 less	 bureaucratic	
operating	environment	for	GPs	and	help	foster	schemes	
such	as	those	involving	pharmacists	more	closely	in	the	
monitoring	and	delivery	of	patient	care.
In	the	field	of	community	nursing,	 innovations	 like	–	for	
instance	 –	 the	 establishment	 of	 ‘virtual	 wards’11	 and	
common	 systems	 of	 IT	 based	 health	 and	 social	 care	
record	 keeping	 also	 promise	 enhanced	 performance.	
Whatever	 the	 failures	 and	 distractions	 of	 the	 past,	
the	 need	 to	 invest	 in	 primary	 health	 and	 social	 care	
improvements	 is	 now	 recognised	 at	 the	 national	 level	
as	well	 as	 in	 an	 increasing	 number	 of	 localities,	 albeit	
the	amounts	of	time	and	financial	and	human	resource	
needed	 to	 establish	 more	 appropriate	 cultures	 and	
greater	levels	of	trust	and	inter-professional	collaboration	
should	not	be	under-estimated.
Examples	of	excellent	practice	already	exist	throughout	
the	country.	Yet	sustainable	progress	may	prove	difficult	
to	achieve	in	areas	which	have	been	less	likely	to	attract	
‘champions’	 for	 new	 ways	 of	 working.	 From	 a	 broad	
sociological	 perspective	 resistance	 to	 change	 is	 often	
greatest	in	settings	where	people	lack	shared	confidence	
in	their	ability	to	adopt	innovative	ways	of	working,	and	
10	That	is,	policies	aimed	at	encouraging	more	people	to	initially	
present	for	diagnosis	and	treatment	in	‘healthy	living	pharmacies’	
or	similar	settings.
11	Which	allow	people	living	in	the	community	to	temporarily	receive	
‘hospital	at	home’	support
might	have	more	reason	than	most	to	doubt	the	integrity	
of	 those	advocating	changes	 like	hospital	bed	number	
reductions.
Effective	change	strategies	are	therefore	likely	to	permit	
significant	 degrees	 of	 variation.	 From	 a	 social	 theory	
perspective	 voluntarily	 led	 and	 accepted	 community	
progress	 is	 likely	 to	 be	 plural	 rather	 than	 regimented.	
Undue	centralisation	can	create	 ‘dependency’	cultures	
that	sap	entrepreneurialism	and	 inhibit	change	through	
over-rigid	 remunerative	 and	 regulatory	 structures.	
Nevertheless,	many	members	of	the	public	expect	and	
value	service	consistency	between	 localities,	and	there	
are	dangers	that	in	the	absence	of	adequate	interventions	
that	 provide	 national	 direction	 and	 the	 sustained	
incentivisation	of	agreed	primary	health	and	social	care	
improvements,	 NHS	 development	 will	 continue	 to	 be	
patchy	 and	 variable	 to	 an	 extent	 which	 confuses	 and	
dismays	 a	 significant	 proportion	 of	 its	 users.	 Without	
consolidating	 action,	 even	 performance	 in	 exceptional	
areas	may	 in	 time	 slip	 back	when	 charismatic	 leaders	
leave	 or	 special	 funding	 arrangements	 (and	with	 them	
the	‘Hawthorne	effects’	likely	to	be	associated	with	pilot	
projects)	come	to	an	end.
Such	observations	point	to	the	potential	value	of	revised	
nation-wide	payment	systems	that	reward	and	normalise	
cross	 boundary	 data	 sharing	 and	 ‘joined	 up’	 service	
delivery,	 as	 opposed	 to	 ‘silo’	 working	 and	 sectional-
interest	 focused	 ‘business	 as	 usual’	 attitudes	 (Porter	
and	Lee,	2013).	Such	measures	could	prove	valuable	in	
facilitating	more	effective	work	sharing	between	General	
Practice	and	Community	Pharmacy,	as	well	as	in	higher	
profile	 contexts	 such	 as	 improving	 health	 and	 social	
care	 coordination	 in	 order	 to	 facilitate	 earlier	 hospital	
discharges.	 Without	 measures	 that	 effectively	 create	
increased	 capacity	 in	 General	 Practice	 for	 the	 support	
of	people	with	 relatively	complex	 requirements	 it	will	be	
difficult	to	achieve	significant	changes	in	hospital	utilisation.
However,	 financial	 incentives	 are	 not	 the	 only	 drivers	 of	
cultural	and	functional	adaptations.	In	the	NHS	individuals	
and	groups	and	local	government	also	need	to	resolve	a	
range	of	ethical	and	value	based	dichotomies	that	have	in	
the	past	stood	in	the	way	of	better	care	coordination	and	
productive	joint	working.	Issues	that	should	be	more	openly	
discussed	and	better	understood	include:
•	 Access ‘versus’ continuity?	 The	 available	 research	
points	 to	 tensions	 between	 meeting	 calls	 for	 rapid	
diagnosis	and	care	when	individuals	are	in	acute	distress	
or	seeking	to	manage	common	problems	that	may	be	
discomforting	but	are	perceived	as	normal	daily	matters,	
as	 against	 requirements	 for	 ‘high	 trust’	 personal	 care	
that	are	likely	to	demand	continuing	relationship	based	
responses.	 The	 latter	 are	most	 needed	when	 people	
are	 facing	 potentially	 life	 threatening	 or	 life	 changing	
difficulties.	 Coping	 with	 the	 latter	 can	 be	 seen	 as	
‘special’	in	that	it	calls	for	identity	shifting	psychological	
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and	 behavioural	 accommodations.	 All	 health	 systems	
struggle	 with	 providing	 services	 to	 meet	 these	 two	
different	 types	 of	 need	 in	 an	 empathetic,	 adequately	
coordinated	and	affordable	manner.
There	is	a	case	for	saying	that	health	service	users	should	
be	seen	by	 their	GPs	even	when	 they	are	expressing	
‘common	 care’	 needs,	 in	 order	 to	 build	 therapeutic	
relationships	and	mutual	understanding.	However,	there	
is	also	an	obvious	risk	of	‘swamping’	General	Practice	
with	tasks	such	as	treating	transient	infections,	providing	
immunisations	 and	 managing	 conditions	 like	 ‘normal’	
hypertension,	stable	diabetes,	asthma	or	COPD.
Larger	 general	 practices	 may	 manage	 this	 tension	
by	 differentiating	 between	 service	 provision	 by	 a	
patient’s	 ‘own	 doctor’	 and	 care	 offered	 by	 other	
staff.	However,	from	both	a	service	user	and	a	public	
health	perspective,	building	arrangements	via	which	
providers	 such	 as	 community	 pharmacy	 based	
staff	can	safely	and	cost	effectively	offer	convenient	
‘pharmacy	first’	access	to	preventive,	diagnostic	and	
common	 illness	 treatment	 services	 is	 a	 potentially	
desirable	way	 forward.	 This	will	 be	 particularly	 so	 if	
it	can	be	achieved	in	ways	that	enhance	the	integrity	
of	the	health	records	available	to	GPs	and	their	long	
term	relationships	with	the	people	they	serve.
•	 Large integrated systems ‘versus’ small diverse 
organisations?	 As	 previously	 noted,	 this	 is	 an	
important	topic	in	the	contexts	of	both	general	practice	
and	community	pharmacy.	Larger	service	providers	are	
by	definition	likely	to	be	better	able	to	realise	benefits	
associated	with	the	delivery	of	care	at	increased	scale,	
even	if	in	practice	this	goal	is	not	normally	achieved	via	
mergers	 and	 ‘take-overs’.	 Yet	 there	 is	 also	 evidence	
that	 small	 organisations	 can	 provide	 environments	
which	are	less	bureaucratic	and	in	which	it	is	easier	to	
offer	 support	 that	 is	 experienced	as	person	centred.	
It	can	be	argued	that	the	UK	appears	to	be	relatively	
strongly	 focused	on	 forming	 large	organisations	with	
markedly	hierarchical	power	and	 reward	distributions	
as	 compared	 with	 other	 European	 countries,	 albeit	
there	 is	 also	 evidence	 that	 the	 performance	 of	NHS	
doctors	 in	 communicating	 effectively	 with	 individual	
patients	is	robust	in	international	terms.
Despite	the	traditional	role	of	independent	practitioners	
in	 the	 primary	 medical	 and	 pharmaceutical	 care	
systems,12	 the	 NHS	 may	 have	 been	 less	 oriented	
towards	the	pursuit	of	benefits	likely	to	be	associated	
with	 small	 professionally	 led	 organisations	 working	
in	 circumstances	 which	 encourage	 effective	
12	Community	pharmacy	is	to	an	increasing	degree	provided	via	
large	private	wholesaler	owned	chain	pharmacies,	which	puts	
pharmacists	in	a	different	position	from	most	GPs.	Business	
processes	can	be	designed	at	‘higher’	organisational	levels	
are	performance	managed	through	to	delivery.	However,	such	
approaches	may	not	be	suitable	for	the	provision	of	patient	
centred	personal	care	in	relatively	complex	situations.
collaboration	 than,	 say,	 its	 French	 or	 Belgian	
counterparts.13	 To	 the	 extent	 that	 this	 conjecture	 is	
true,	multiple	sociological	and	economic	 factors	are	
likely	to	underlie	it.	But	for	the	purposes	of	this	analysis	
the	key	point	to	emphasise	is	that	approaches	such	
as	the	formation	of	local	Health	Care	Federations	and	
the	 NAPC’s	 ‘complete	 clinical	 community’	 concept	
(Chana,	2015)	seek	to	bridge	the	‘large	versus	small’	
organisation	 divide.	 Their	 goal	 is	 to	 combine	 the	
benefits	 of	 personal	 relationship	 based	 transactions	
with	systemically	embedded	competencies.
The	 practicalities	 of	 achieving	 local	 and/or	 national	
remuneration	and	governance	arrangements	that	can	
translate	this	promise	into	a	day-to-day	reality	have	not	
yet	 been	 fully	 addressed.	However,	 recent	 research	
on	topics	 like	 increasing	productivity	via	establishing	
self-managed	organisations	(Laloux,	2014)	suggests	
that	meaningful	progress	in	this	direction	is	possible,	
should	the	stakeholders	in	primary	health	and	social	
care	be	adequately	motivated	to	seek	it.
•	 Managerialism ‘versus’ professionalism?	
Following	on	from	the	above,	the	managerial	revolution	
that	 has	 to	 varying	 degrees	 occurred	 in	 developed	
country	 health	 services	 since	 the	 1960s	 remains	
controversial,	as	 is	the	role	of	non-clinical	managers	
in	directing	 the	delivery	of	good	quality	care.	To	 the	
extent	 that	 health	 professionals	 are	 not	 trusted	 to	
serve	public	interests	in	optimising	the	value	derived	
from	health	care	resources	(Porter,	2009)	or	lack	the	
organisational	skills	needed	to	achieve	better	service	
delivery,	 a	 competent	managerial	 cadre	 is	 required.	
Yet	 non-clinical	 managerial	 groups	 can	 develop	
counter-productive	 vested	 interests	 and	 lack	 insight	
into	key	aspects	of	service	provision.	It	is	arguable,	if	
also	contestable,	that	only	people	involved	directly	in	
delivering	care	are	genuinely	well	placed	to	coordinate	
the	processes	of	interaction	needed	to	achieve	good	
medical	and	wider	health	and	social	outcomes.
In	recent	decades	many	commentators	have	stressed	
the	need	 to	closely	 involve	health	professionals	and	
service	 users	 alike	 in	 care	 quality	 management	 in	
order	 to	help	make	the	NHS	a	responsive,	 learning,	
organisation	 (Berwick,	 2013).	 New	 Federation/
Primary	Care	Home	based	approaches	to	the	delivery	
of	well-coordinated	health	and	social	care	could	help	
achieve	this	end,	even	though	there	can	be	no	simple	
resolution	 to	 the	 challenges	 inherent	 in	 enabling	
skilled	and	highly	motivated	people	to	work	together	
13	From	a	constitutional	perspective	the	primary	mission	of	the	
NHS	may	be	taken	to	be	maximising	public	health,	rather	than	
assuring	individuals’	rights	of	access	to	effective	treatments.	
Existing	management	and	funding	arrangements	reflect	this,	albeit	
within	a	fragmented	neo-liberal	institutional	level	NHS	governance	
framework.	It	could	be	suggested	that	optimally	effective	health	
and	social	care	systems	are	likely	to	embody	values	that	give	
priority	to	protecting	the	wellbeing	and	dignity	of	both	patients	and	
health	care	providers	as	individuals	in	society,	rather	than	as	units	
that	collectively	make	up	more	important	entities.
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in	ways	that	allow	the	resources	collectively	available	
to	them	to	be	used	in	ways	that	optimise	outcomes	
for	service	users.
•	 Population health ‘versus’ individual care?	
Despite	 the	 work	 of	 pioneers	 such	 as	 Julian	 Tudor	
Hart	 (1971),	 traditional	medical	 and	 pharmaceutical	
care	models	can	become	unduly	focused	on	treating	
individuals	 as	 distinct	 from	 addressing	 community	
wide	 determinants	 of	 heath	 and	 illness.	 At	 the	
same	 time	public	health	based	approaches	may	on	
occasions	 be	 accused	 of	 sacrificing	 personal	 care	
standards	and	preferences	in	the	pursuit	of	population	
level	health	improvement	opportunities.
Such	 conflicts	 may	 be	 most	 likely	 to	 occur	 when	
resources	are	 limited	and	multiple	unmet	health	and	
social	care	needs	exist,	even	if	affluence	can	also	be	a	
cause	of	perverse	behaviours.	What	can	be	said	with	
confidence	 is	 that	 in	 developed	nations	 like	 the	UK	
good	quality	care	 for	both	 individuals	and	 the	entire	
population	 should	 be	 achievable,	 despite	 claims	
it	 is	 in	 danger	 of	 becoming	 unaffordable.	 In	 reality	
perhaps	the	greatest	risk	 is	that	failures	to	meet	the	
experienced	needs	of	all	service	users	and	community	
groups	in	fair	and	empathetic	ways	might	in	the	long	
term	undermine	political	support	for	the	redistributive	
funding	mechanisms	required	by	universal	health	and	
social	care	systems.
Ensuring	 that	 care	 investment	 and	 delivery	 choices	
are	 as	 far	 as	 possible	 taken	 with,	 rather	 than	 for,	
communities,	 and	 are	 at	 the	 same	 time	 informed	
by	the	best	available	evidence	and	analysis,	 is	 likely	
to	 offer	 the	 most	 productive	 approach	 to	 assuring	
decision	 making	 that	 is	 perceived	 as	 reasonable	
and	 just.	 The	 extent	 to	which	 this	 can	be	 achieved	
by	authorities	that	are	remote	from	service	users,	or	
by	groups	that	 lack	credibility	as	to	their	capacity	to	
understand	 both	 the	 biological	 and	 psycho-social	
aspects	of	health	and	illness,	is	inevitably	limited.
•	 Self-care ‘versus’ professional care?	 Traditional	
professional	education	can	on	occasions	encourage	
beliefs	 to	 the	 effect	 that	 health	 and	 social	 care	 is	
something	 that	 is	 ‘done’	 to	 passive	 patients	 by	
qualified	staff.	In	reality,	desired	health	and	social	care	
outcomes	are	normally	co-produced	by	the	combined	
efforts	of	 service	users	and	providers,	 coupled	with	
informal	 inputs	 from	 other	 community	 members.	
This	is	as	true	in	fields	like,	for	instance,	orthopaedic	
surgery	and	the	effective	use	of	anticancer	medicines	
as	 it	 is	 in	 areas	 such	 as	 community	 nursing	 or	 the	
provision	 of	 smoking	 cessation	 support	 and	 other	
preventive	interventions.
Free-standing	 community	 pharmacies	 are	 an	
important	 source	 of	 self-care	 products	 and	 advice.	
Failures	to	link	pharmacy	based	work	at	the	interface	
between	self-care	and	 the	professional	 treatment	of	
illness	more	 robustly	 to	 the	 ‘mainstream’	delivery	of	
medical	care	by	GPs	and	other	health	professionals	
could	 miss	 important	 opportunities	 for	 the	 further	
transformation	 of	 services	 and	 the	 better	 use	 of	
resources.
Dispensing	medicines	 via	 the	 existing	 disseminated	
network	 of	 Community	 Pharmacies	 (at	 present	 90	
per	cent	of	people	in	England	live	within	20	minutes	
walk	of	a	pharmacy,	 rising	 to	close	 to	100	per	cent	
in	urban	areas	–	Todd	et	al,	2014)	currently	–	along	
with	related	services	–	costs	English	taxpayers	in	the	
order	of	£2.5	billion	per	annum.	Some	commentators	
believe	 that	 this	 sum	could	be	 significantly	 reduced	
by	 computerising	 the	 transmission	 of	 prescriptions	
and	concentrating	dispensing	 in	 factory/warehouse-
like	 facilities.	 Most	 medicines	 and	 allied	 products	
could,	 the	 proponents	 of	 this	 approach	 believe,	 be	
delivered	directly	to	patients’	homes	or	to	facilities	like	
GP	surgeries	or	collection	centres	in	supermarkets	or	
other	retail	outlets.
There	 is	 evidence	 that	 such	 strategies	 can	 save	
costs	 and/or	 release	 pharmacists’	 time	 for	 clinical	
work.	 However,	 the	 net	 savings	 such	 measures	
are	 likely	 to	 generate	 are	 –	 assuming	 that	 an	 easily	
accessible	 capacity	 to	 provide	 the	 25	 per	 cent	 or	
so	of	all	prescription	 items	classified	as	 ‘acute’	 in	a	
timely	manner	is	preserved	–	likely	to	be	considerably	
less	 than	 is	 sometimes	 suggested.	 Rather	 than	
weakening	the	existing	Community	Pharmacy	service	
to	a	point	where	significant	numbers	of	people	 lose	
good	physical	access	to	dispensing	and	other	valued	
services	 a	more	 cost	 effective	 strategy	 could	 be	 to	
move	as	rapidly	as	possible	towards	extending	health	
care	provision	 in	 local	 pharmacies,	both	 to	 improve	
service	access	and	reduce	pressures	elsewhere	in	the	
NHS.
Some	decision	makers	may	 fear	 negative	 reactions	
to	 such	 policies,	 especially	 if	 more	 vigorously	 led	
attempts	 to	 realise	 this	 option	were	 to	 be	pursued,	
and	some	sectional	interests	may	wish	to	exaggerate	
such	 concerns.	 But	 both	 doctors	 and	 patient	
representatives	 interviewed	 during	 the	 qualitative	
research	undertaken	 for	 this	 report	 agreed	 that	 this	
way	forward	should	now	be	pro-actively	explored.
Towards value based care
To	date	NHS	leaders	have	often	taken	a	disappointingly	
binary	 (‘one	 side	 or	 the	 other’)	 approach	 to	 resolving	
the	 dichotomies	 outlined	 above.	 At	 the	 same	 time	
institutionally	focused	governance	bodies	such	as	Trust	
Boards	and	inadequately	informed	commissioning	bodies	
have	frequently	lacked	a	comprehensive	understanding	
of	how	best	to	serve	public	physical	and	mental	health	
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interests.	With	 the	possible	exception	of	more	 ‘market	
led’	 care	 providers	 such	 as	 community	 pharmacists,	
it	might	 also	be	 said	 that	 service	user	 ‘wants’	 are	 too	
often	 seen	as	 false	 signals	 that	health	and	social	 care	
providers	 should	 ignore	 in	 order	 to	 concentrate	 on	
meeting	‘legitimate	needs’.
However,	 in	October	2015	the	Chief	Executive	of	NHS	
England,	Simon	Stevens,	endorsed	a	pilot	programme	
for	 care	 delivery	 based	 on	 the	 ‘Primary	 Care	 Home’	
model	 (Roberts,	 2015).	 Pursued	 appropriately,	 such	
strategies	could	not	only	help	to	further	develop	better	
co-ordinated	 ‘close	 to	 home’	 care	 for	 patients	 but	 in	
addition	 create	 opportunities	 for	 more	 sophisticated	
approaches	 to	 balancing	 individual	 and	 community	
requirements.
As	 already	 noted,	 NHS	 England	 has	 also	 recently	
announced	 funding	 for	 the	 experimental	 employment	
of	 several	 hundred	 clinical	 community	 pharmacists	 in	
General	Practice.	This	 is	 a	desirable	 step	 forward	 that	
might	 in	 time	 help	 overcome	 some	 of	 the	 workforce	
problems	 currently	 affecting	 primary	 care	 provision.	
However,	 it	 should	 not	 be	 used	 to	 justify	 neglecting	
the	 wider	 development	 of	 Community	 Pharmacy,	 or	
discourage	 the	 addressing	 of	 questions	 like	 ‘how 
can the existing body of community pharmacies and 
pharmacists be enabled to take a progressively more 
active part in local primary care Federations?’.
There	 is	currently	considerable	 interest	 in	reforms	such	
as	 what	 is	 (in	 some	 respects	 potentially	 misleadingly)	
termed	the	devolution	of	health	and	social	policy	making	
and	service	delivery	responsibilities	to	local	authority	led	
regional	 bodies.	 The	most	 notable	 example	 of	 this	 to	
date	exists	 in	the	Greater	Manchester	area.	Advocates	
of	the	budget	and	commissioning	responsibility	pooling	
that	 this	will	 result	 in	believe	 it	will	 integrate	health	and	
social	care,	and	give	elected	local	councillors	a	stronger	
role	in	directing	service	developments.
This	could	permit	 innovative	contracting	or	other	forms	
of	 service	 funding	 and	 in	 theory	 at	 least	 allow	 service	
provision	in	England	to	become	more	like	the	system	that	
exists	in	States	such	as	Sweden	(Box	8).	The	potential	
importance	 of	 such	 reforms	 should	 not	 therefore	
be	 ignored	 (McKenna	 and	 Dunn,	 2015).	 However,	
simplistic	attempts	to	introduce	them	in	ways	that	ignore	
important	cultural	and	allied	success	determinants	must	
be	guarded	against.
Some	critics	warn	that	without	explicit	safeguards	such	
steps	might	in	the	UK	in	future	lead	to	stricter	cash	limits	
on	overall	health	and	social	care	spending	(legally,	local	
authorities	 cannot	 operate	 with	 annual	 deficits)	 while	
at	 the	 same	 time	 reducing	 national	 level	 pressures	 to	
increase	 public	 health	 and	 social	 care	 outlays	 on	 the	
care	of	people	with	conditions	ranging	from	cancers	to	
Alzheimer’s	 Disease	 to	 advanced	 Western	 European	
levels.	Another	cause	for	concern	is	that	a	strengthening	
of	 local	 political	 control	 in	 the	 health	 sphere	 could	 in	
some	circumstances	block	the	development	of	‘Primary	
Care	 Homes’	 and	 services	 provided	 directly	 by	 local	
professionals	in	ways	that	make	them	more	directly	and	
fully	accountable	to	their	individual	users.
There	 are	 allied	 uncertainties	 surrounding	 the	 future	
role	of	CCGs.	Some	observers	argue	that	they	are	not	
consistently	fit	for	purpose	in	relation	to	commissioning	
secondary	 level	 hospital	 care,	 or	 community	 services	
other	 than,	perhaps,	 narrowly	defined	primary	medical	
care.	Even	in	the	General	Practice	context	the	ability	of	
most	CCGs	to	act	has	until	recently	been	very	limited.
Developments	such	as	those	in	Manchester	and	recently	
in	Cornwall	might	in	time	lead	to	new	structures	that	will	
replace	CCGs	as	they	were	established	in	2013.	Likewise,	
in	 some	 localities	 the	 emergence	 of	 fully	 integrated	
primary	 and	 secondary	 NHS	 provider	 organisations	
able	to	take	comprehensive	responsibility	for	developing	
services	 in	 their	 localities	might	 also	eventually	 lead	 to	
further	 reforms	 in,	or	even	 the	abolition	of,	 the	current	
English	NHS	commissioning	arrangements	based	on	a	
purchaser/provider	divide.
However,	the	past	record	of	serial	structural	changes	in	the	
NHS	is	not	encouraging.	Removing	or	radically	reshaping	
CCGs	before	they	have	had	time	to	become	more	firmly	
established	and	define	how	best	they	can	function	might	
well	 have	 perverse	 consequences,	 not	 least	 because	
there	 are	 presently	 important	 opportunities	 for	 further	
extending	their	roles.	The	view	taken	here	is	therefore	that	
the	 most	 productive	 approach	 from	 a	 health	 outcome	
improvement	perspective	will	be	to	focus	on	developing	
Primary	Care	Federations	in	ways	that	will	allow	them	to	
act	effectively	as	budget	holding	comprehensive	service	
delivery	 organisations,	 working	 with	 CCG	 support	 and	
secondary	care	hospital	 involvement	as	 local	conditions	
permit.
Achieving	 this	will	 very	 probably	 demand	 a	mixture	 of	
‘soft’	 and	 ‘hard’	 interventions.	 Examples	 range	 from	
the	 further	 encouragement	 of	 public	 and	 professional	
debate	about	the	future	of	primary	care	through	to	the	
financial	 incentivisation	of	better	 joint	working	between	
general	practices	and	 independently	sited	pharmacies.	
Important	questions	as	to	how	this	can	best	be	done	in	
ways	consistent	with	patient	and	public	interest	in	choice,	
as	well	as	in	technical,	allocative	and	social	efficiency	and	
the	 improvement	 of	 professional	motivation,	 remain	 to	
be	resolved.	But	they	are	at	least	beginning	to	be	more	
fully	considered.
Even	if	each	community	pharmacy	in	England	were	only	
able	–	over	and	above	their	current	contributions	–	to	take	
on	10	per	cent	of	the	average	general	practice’s	existing	
clinical	and	allied	workload	over,	say,	the	next	five	years,	
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this	 could	 release	 approaching	 5,000	 GP	 FTEs14	 and	
similar	amounts	of	practice	staff	time	for	other	activities.	
Given	the	challenges	 facing	the	NHS,	 the	possibility	of	
gains	of	this	magnitude	should	not	be	overlooked.
For	 some,	 the	 barriers	 still	 to	 be	 overcome	 in	 order	
to	 achieve	 such	 transformative	 progress	 may	 seem	
daunting.	But	 the	original	NHS	was	effectively	 created	
14	Full	time	equivalent	workforce	members
in	the	two	bleak	post-war	years	between	the	passage	of	
the	NHS	Act	in	November	1946	and	its	establishment	in	
July	1948.	Seen	from	this	standpoint,	tasks	like	further	
improving	 joint	working	between	General	Practice	and	
Community	 Pharmacy	 to	 provide	 better	 care	 access	
and	open	the	way	to	enhanced	health	and	social	service	
coordination	 should	 not,	 in	 today’s	 relatively	 benign	
social	and	economic	environment,	prove	insuperable.
Box 8. Health and Social Care in Sweden
As	with	 the	 NHS	 in	 the	 UK,	 health	 care	 provision	 in	
Sweden	(which	in	part	because	of	its	wartime	neutrality	
established	 its	 modern	 era	 system	 before	 Britain	
was	able	to	so	in	the	late	1940s)	 is	a	universal	public	
service	financed	from	taxation.	As	 in	this	country	and	
most	other	Western	European	nations,	patient	choice	
and	 competition	 between	 alternative	 providers	 have	
increasingly	 become	 seen	 as	 important	 priorities,	
while	public	monopoly	provision	is	no	longer	regarded	
essential.	 But	 unlike	 the	 situation	 with	 the	 NHS,	
Swedish	health	care	provision	is	based	on	the	principle	
of	subsidiarity.	This	requires	responsibility	for	financing	
and	 ensuring	 appropriate	 standards	 to	 lie	 at	 the	
lowest	 possible	 local	 government	 administrative	 level	
(Bidgood,	2013).
Sweden	spends	9-10	per	cent	of	its	GDP	on	it	publicly	
supported	health	system.	This	is	a	little	above	the	British	
level.	About	70	per	cent	of	this	sum	is	raised	by	the	21	
counties	and	290	municipalities	that	together	serve	the	
country’s	9	million	people.	Local	charges	are	often	levied	
at	a	flat	rate,	but	central	government	grants	funded	by	
progressive	national	taxation	serve	to	even	out	resource	
inequalities.	 Primary	 care	 is	 delivered	 by	 more	 than	
1100	public	(owned	by	the	county	councils)	and	private	
(mostly	owned	by	companies	or	cooperatives)	PCOs.	
Team-based	primary	care	facilities	with	four	to	six	GPs	
together	with	district	nurses,	nurses	and	depending	on	
local	needs	physiotherapists,	occupational	 therapists,	
psychologists,	and	social	welfare	counsellors	represent	
the	most	common	practice	model	in	Sweden.
Another	 important	 characteristic	 is	 that,	 as	 opposed	
to	 the	 UK	 position,	 publicly	 supported	 social	 care	 in	
Sweden	 is	 better	 funded	 and	 of	 significantly	 higher	
quality	across	a	range	of	areas,	including	–	for	instance	
–	 the	 provision	 of	 residential	 care	 for	 older	 people	
living	 with	 disabilities.	 Whereas	 Britain	 spends	 only	
about	one	per	cent	of	 its	GDP	on	such	support,	 the	
equivalent	 Swedish	 proportion	 is	 in	 the	 order	 of	 3	
per	cent.	Recent	changes	announced	after	 the	2015	
Comprehensive	Spending	Review	may	prove	sufficient	
to	check	the	relative	decline	in	social	care	provision	in	
England	seen	in	recent	years	(see	main	text).	But	they	
will	not	contribute	to	closing	the	gap	between	Swedish	
and	British	public	investment	levels	in	this	key	area.
The	extent	to	which	such	data	are	fully	comparable	is	
questionable.	 It	 would	 be	 wrong	 to	 over-emphasise	
the	extent	to	the	Swedish	welfare	system	as	a	whole	
has	outperformed	that	of	the	UK	over	the	last	seventy	
years.	In	some	areas,	such	as	successfully	assimilating	
large	 migrant	 populations	 with	 plural	 care	 and	 allied	
needs,	Britain	may	have	done	relatively	well.	However,	
from	 an	 ageing	 population	 perspective	 a	 persistent	
weakness	 at	 the	 heart	 of	 the	 NHS	 and	 its	 partner	
agencies	 has	 been	 the	 inconsistency	 between	 ‘free’	
medical	and	allied	service	provision	and	 the	 fact	 that	
‘social’	 care	 for	 people	 with	 conditions	 such	 as	 (for	
example)	dementias	has	typically	been	charged	for	until	
individual	or	sometimes	family	funds	have	in	effect	been	
exhausted.	 This	 has	 on	 occasions	 created	 perverse	
incentives	to	classify	health	care	as	social	care,	which	
perhaps	helps	explain	the	NHS’s	chequered	record	of	
community	nursing	service	provision.
At	other	times	it	has	either	driven	the	avoidable	use	of,	
or	 ‘blocking’	of,	 relatively	expensive	hospital	 facilities.	
More	adequate	community	provisions	could	moderate	
such	problems,	while	simultaneously	delivering	better	
overall	outcomes.	It	may	be	suggested	that	health	and	
social	care	 ‘integration’	could	 in	 future	eliminate	such	
problems	in	England,	and	there	is	evidence	that	the	co-
location	of	primary	care	workers	of	all	 types	 together	
with	 development	 of	 good	 personal	 relationships	
and	 cooperative	 cultures	 can	 generate	 important	
advantages.	However,	 if	 no	 adequate	 solution	 to	 the	
underlying	challenge	of	resolving	the	disparity	between	
‘means	 tested’	social	care	provision	and	 ‘free’	health	
care	is	found,	forming	structurally	unified	provider-side	
agencies	in	the	pursuit	of	better	care	coordination	may	
in	practice	prove	little	more	than	‘magic	thinking’.
It	is	also	of	note	that	in	Sweden	efforts	have	been	made	
to	distinguish	between	the	provision	of	health	care	as	
a	bio-medical	function	as	compared	to	social	care	as	
being	an	activity	aimed	at	enabling	satisfactory	ways	of	
life	to	be	maintained,	and	protecting	 individual	choice	
and	 required	 levels	 of	 personal	 autonomy	 in	 every	
aspect	 of	 existence	 (Lindström	 Karlsson,	 2015).	 The	
rhetoric	 of	 bio-psycho-social	 care	 may	 suggest	 that	
confusions	between	nursing	and	social	care	can	easily	
be	 avoided.	 Yet	 inadequately	 informed	 attempts	 to	
conflate	the	two	might	have	unwanted	consequences	
that	 are	 more	 difficult	 to	 avoid	 than	 is	 commonly	
recognised.	
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Conclusion
The	NHS	remains	one	of	the	better	organised	and	resourced	
health	care	systems	in	the	world.	But	to	meet	the	twenty	
first	century	needs	of	people	in	England	and	the	other	UK	
nations	as	well	as	possible	within	the	resources	available	it	
will	have	to	improve	its	capacity	to	offer	convenient	access	
to	preventive	and	‘common	need’	diagnostic	and	treatment	
services	 to	people	 at	 all	 stages	of	 their	 lives.	 There	 is	 in	
addition	a	growing	requirement	for	well-coordinated	social	
and	health	care	to	provide	more	complex	personal	support	
to	patients	at	high	risk	of	suffering	avoidable	episodes	of	
serious	 illness	 and	 ultimately	 losing	 their	 independence.	
Although	 there	 is	evidence	 that	 in	 international	 terms	 the	
current	performance	of	the	UK	is	already	better	than	that	
of	some	other	advanced	countries,	further	 improvements	
should	be	possible.
Enhancing	primary	health	and	social	services	offers	an	
important	 key	 to	 raising	 the	 performance	 of	 the	 entire	
NHS.	 As	 the	 UK’s	 demographic,	 epidemiological	 and	
social	 transitions	continue,	and	 innovative	technologies	
offer	new	communication	and	therapeutic	opportunities	
for	both	professionals	and	individuals	seeking	to	maintain	
their	 own	 health,	 the	 balance	 of	 care	 provision	 will	
inevitably	shift.	But	achieving	optimal	change	will	require	
good	 insight,	careful	planning	and	firm	commitment	 to	
meeting	 personal	 and	wider	 public	 requirements	 at	 all	
levels	of	the	health	and	social	care	system,	from	those	
of	families	and	local	practitioner	communities	through	to	
specialised	hospital	care	and	central	policy	making.
The	 unique	 universal	 care	 attributes	 of	 British	 general	
medical	 practice	means	 that	 it	 can	 serve	 as	 a	 central	
plank	 for	 continuing	 NHS	 development,	 based	 on	
both	 trusting	 relationships	 with	 individuals	 and	 insight	
into	 the	 needs	 of	 local	 communities.	 There	 is	 also	 a	
large,	 if	 fragmented,	 body	 of	 evidence	 indicating	 that	
Community	Pharmacy	can	beneficially	play	an	extended	
part	 in	 delivering	 accessible	 health	 care,	 as	well	 as	 in	
tasks	such	as	reducing	prescription	errors	and	facilitating	
better	medicines	use	amongst	priority	groups.	If	General	
Practice	and	Community	Pharmacy	can	more	effectively	
combine	 their	 contributions	 this	 would	 open	 the	 way	
to	 both	 better	 public	 health	 and	 significant	 overall	
NHS	efficiency	gains,	whatever	the	uncertainties	of	the	
financial	environment	that	lies	ahead.
Some	 movement	 towards	 this	 end	 has	 already	 been	
achieved.	However,	no	health	service	has	yet	achieved	
definitive	 system-wide	 progress	 towards	 realigning	 the	
working	relationships	between	community	pharmacists	
and	doctors	in	ways	that	reflect	the	full	levels	of	gain	that	
pilot	 schemes	 and	 local	 examples	 of	 excellence	 show	
are	possible.
In	England	and	elsewhere	the	fundamental	reasons	for	
this	 apparent	 ‘road	 block’	 include	 lagged	 consumer	
expectations,	 cultural	 differences	 between	 the	
professions	 and	 historically	 rooted	 variations	 in	 the	
ways	 community	 pharmacists	 and	 GPs	 are	 educated	
and	 remunerated.	 These	 differences	 reflect	 important	
distinctions	between	the	tasks	of	optimising	medicines	
supply	and	use	and	that	of	delivering	holistic	clinical	care.	
Yet	barriers	to	closer	joint	working	are	now	fading,	along	
with	some	if	not	all	of	the	traditional	–	in	part	social	class	
defined	 –	 boundaries	 between	 medicine,	 pharmacy,	
nursing	and	social	work	inherited	from	the	past.
The	promise	of	the	NAPC’s	Primary	Care	Home	model	
is	that	it	offers	a	route	towards	establishing	better	linked	
funding	 arrangements	 for	 local	 community	 medical,	
pharmacy	 and	 nursing	 services,	 and	 a	 platform	 for	
coordinating	 health	 and	 social	 service	 provisions.	 The	
extent	 to	 which	 progress	 towards	 this	 end	 could	 and	
should	 be	 facilitated	 by	 adaptive	 national	 contracts	
as	 distinct	 from	 multiple	 unique	 local	 agreements	
is	 presently	 uncertain.	 But	 constructive	 change	 will	
be	 possible	 if	 public	 and	 sectional	 managerial	 and	
professional	 interests	are	adequately	aligned,	and	GPs	
and	 pharmacists	 are	 sufficiently	 motivated	 to	 take	
effective	 action.	 For	 independently	 sited	 community	
pharmacy	in	particular	a	failure	to	invest	sufficient	effort	
in	 establishing	better	 integrated	primary	 care	provision	
would	–	whatever	the	perceived	hazards	of	pro-actively	
seeking	change	–	almost	certainly	result	in	reductions	in	
its	standing	and	role.
There	 is	 a	 need	 for	 individual	 health	 professionals	 to	
accept	risk	and	 lead	purposeful	service	 improvements.	
Undue	dependency	on	central	 leadership	 is	unlikely	 to	
generate	viable	new	health	care	paradigms.	Successful	
progress	 towards	 the	 formation	 of	 well	 aligned	
‘complete	clinical	communities’	involving	all	primary	care	
professionals	 will	 be	 a	 significant	 step	 in	 the	 ongoing	
evolution	of	this	country’s	health	and	social	care	system.	
It	might	also	help	guide	the	development	of	cost	effective	
universal	health	care	in	other	nations.
However,	having	recognised	the	value	of	local	innovation	
and	enterprise,	national	recognition	of	the	importance	of	
supporting	better	primary	care	provision	is	also	vital.	One	
of	the	key	conclusions	of	this	report	is	that	establishing	
more	effectively	linked	financial	incentives	is	a	vital	priority.	
Without	 these	 there	 is	 a	 danger	 the	NHS	will,	 despite	
repeated	 superficial	 changes,	 remain	 ‘frozen	 in	 aspic’	
and	–	in	some	ways	like	health	care	in	the	Soviet	Union	
in	 its	 last	 decades	 –	 ultimately	 fail,	 not	 because	 of	 its	
cost	but	through	failures	to	evolve	in	ways	that	build	on	
the	 inherent	strengths	of	General	Practice,	Community	
Pharmacy	and	other	community	care	resources.
Working together
Beyond	 the	 big	 issues	 of	 cultural	 change,	 relationship	
building	and	the	appropriate	financial	support	of	health	
and	 (currently	 means	 tested)	 social	 care,	 prescribing	
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and	dispensing	 lie	close	to	 the	heart	of	what	GPs	and	
pharmacists	 provide	 the	 public.	 Taking	 medicines	 is	
alone	rarely	a	complete	way	of	resolving	serious	health	
problems,	even	when	conditions	are	correctly	diagnosed	
and	effective	drugs	are	appropriately	used.	Nevertheless,	
optimising	 the	supply,	prescribing	and	consumption	of	
pharmaceutical	products	is	a	central	part	of	good	day-
to-day	health	care.
In	 the	past	 there	were	public	 interest	 focused	 reasons	
for	strictly	separating	dispensing	from	the	processes	of	
diagnosis	and	 therapy	selection.	Yet	 in	 the	 twenty	first	
century	advances	in	areas	such	as	public	understanding	
of	 health	 and	 disease,	 professional	 education,	 health	
sector	 regulation	 and	 the	 computerisation	 of	 not	 only	
health	 and	 social	 care	 record	 keeping	but	many	other	
care	related	processes	are	creating	a	new	environment.	
In	the	NHS,	steps	towards	pharmacist	prescribing	have	
been	taken	since	2000.	But	the	evidence	presented	 in	
this	 analysis	 indicates	 once	 again	 that	more	 could	 be	
achieved.
If	in	future	the	skills	of	pharmacists	and	the	potential	of	
the	established	NHS	community	pharmacy	network	are	
–	as	opposed	to	being	lost	or	wasted	–	to	more	effectively	
boost	 the	capacity	of	primary	care	as	a	whole	and	so	
allow	the	NHS	hospital	service	to	function	as	efficiently	
and	 effectively	 as	 possible,	 enabling	 all	 community	
pharmacists	to	be	independent	prescribers	for	‘common	
cause’	complaints	could	well	prove	centrally	important.	
A	 second	central	 conclusion	of	 this	 report	 is	 therefore	
that	further	extending	pharmacy	prescribing	outside	GP	
surgeries	 in	 ways	 that	 strengthen	 rather	 than	 weaken	
the	 ability	 of	 family	 doctors’	 and	 their	 practice	 teams	
to	 provide	 first	 class	 individual	 and	 population	 care,	
and	 which	 also	 optimise	 the	 cost	 effectiveness	 and	
accessibility	of	community	pharmacy	medicines	supply,	
should	be	seen	as	integral	to	the	success	of	the	future	
NHS.
In	the	final	analysis,	promoting	new	and	more	effective	
ways	for	local	professionals	to	work	together	in	order	to	
provide	services	has	much	to	offer	not	only	service	users,	
but	 also	 everyone	 working	 in	 health	 and	 social	 care.	
A	 great	 deal	 of	 the	 responsibility	 for	 developing	more	
effective	relationships	 lies	with	the	 immediate	providers	
of	such	services,	often	because	only	they	–	in	partnership	
with	 service	 users	 –	 can	 fully	 understand	 the	 tasks	 in	
which	 they	 are	 engaged.	 But	 individuals	 and	 groups	
such	 as	 GPs	 and	 pharmacists	 alone	 cannot	 facilitate	
the	overall	 service	 transformation	 that	 is	now	required.	
Excellent	 national	 leadership	 and	 the	 establishment	 of	
more	 appropriate	 financial	 and	governance	 systems	 is	
also	vital	for	the	success	of	services	as	a	whole,	including	
specialist	hospital	provision	alongside	that	of	community	
based	care.
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